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ABSTRACT  
This was a qualitative cross-sectional study which was conducted in health centres, in Blantyre 
district, in southern region of Malawi, between September and December, 2012. Data was 
collected using semi-structured interviews, focus group discussion, review of records and 
observation. Eleven (11) health centres and a referral hospital were included.  29 health workers, 
4 patients and 2 guardians participated in the study. Malawi continues to experience high 
maternal deaths. Although, efforts are in place to reduce maternal deaths, there is need to explore 
how maternal cases are managed in health institutions.  
The study therefore sought;  
1. To assess how first level health care providers in Blantyre manage patients of pre-
eclampsia and eclampsia before referral to the second or third level of care 
2. To assess barriers to proper management of  patients with pre-eclampsia and eclampsia at 
the first level of care 
3. To obtain suggestions for the improvement of the management of patients with pre-
eclampsia and eclampsia at the first level facility of care 
In exploring how pre-eclampsia and eclampsia are managed at the first level of care, the data was 
collected from three sources: health workers at referral facility, health workers at the health 
centres and from patients with pre-eclampsia and eclampsia. The sources were identified based 
on their proximity to the referral hospital and within a single district.  
The study established that, despite a significant awareness of the prevalence of pre-eclampsia and 
eclampsia among pregnant women, health workers both at first level facility of care and at the 
referral facility had numerous challenges in the management of these complications. Some of the 
challenges were patients’ delay in reporting to health centres, inability to diagnose the condition 
due to lack of equipment and materials resources, inability to provide adequate care to  patients 
due to understaffing, lack of or insufficient drugs; delays in transporting  patients to referral  
facility due to poor transport system, skill decay due to infrequent occurrence of cases, lack of 
supervision and feedback from superiors on how the health centres are providing first level care 
to patients. 
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The management of pre-eclampsia and eclampsia at the first level facility of care also varied 
between health centres as well as among individual health workers; indicating need for refresher 
courses to upgrade and synchronize the process of handling the patients. The study further 
established that patients do not have enough knowledge about pre-eclampsia and eclampsia, often 
culturally interpreted.  
In conclusion, management of pre-eclampsia and eclampsia at the first level facility of care 
continues to be challenging in Blantyre, Malawi. Application of knowledge by health workers is 
still weak. Most health workers in first level facilities face numerous problems in the 
management of pre-eclampsia and eclampsia.  
Therefore to improve management of patients with pre-eclampsia and eclampsia, knowledge and 
skills in identification and management of pre-eclampsia and eclampsia at the first level facilities 
need to be improved; health centres must be provided with all the necessary materials and drugs; 
referral cases must be transported to hospital without delay; supervision of pre-eclampsia and 
eclampsia at the first level facility of care must be strengthened. Feedback from the hospital is a 
necessary ingredient for ensuring that pre-eclampsia and eclampsia at the first level facility of 
care is improved. There is also need to strengthen education of patients during antenatal care on 
pre-eclampsia and eclampsia and not to rely on cultural beliefs. Increasing staffing in health 
centres would also help in improving the management of pre-eclampsia and eclampsia at that 
level.  
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DEFINITION OF TERMS 
Preeclampsia: a multisystem disorder which is defined by a raised blood pressure and the 
presence of protein in urine. The condition is a common complication of pregnancy, and can 
occur at any time during the second half of pregnancy, during labour or in the first few weeks 
after delivery. 
Eclampsia: a complication of pre-eclampsia characterized by convulsions in the absence of other 
causes of convulsions such as epilepsy or meningitis. 
 
Lifetime risk of maternal mortality: The probability of maternal death faced by an average 
woman over her entire reproductive life span  
 
Maternal death: Death of a woman while pregnant or within 42 days of termination 
of pregnancy irrespective of its duration and site, from any cause related to or aggravated by the 
pregnancy or its mismanagement, but not from accidental or incidental causes 
 
Maternal mortality ratio: Number of maternal deaths during a given time period per 100 000 
live births during the same time-period  
 
Emergency obstetric care: These are key medical interventions compiled by WHO, UNICEF 
and NFPA that are used to treat the direct obstetric complications that cause the vast majority of 
maternal deaths around the globe. 
 
Basic Emergency Obstetric Care facility: is a health facility which provides the first six signal 
functions that are necessary to save the lives of women with obstetric complications. The services 
include: administration of parenteral antibiotics, parenteral oxytocic drugs, parenteral 
anticonvulsants, manual removal of placenta, removal of retained products of conception and 
assisted vaginal delivery 
Comprehensive Emergency Obstetric Care Hospital: A hospital facility which provides the 
eight signal functions that are necessary to save the lives of women with obstetric complications. 
xv 
 
The services include: administration of parenteral antibiotics, parenteral oxytocicdrugs, parenteral 
anticonvulsants, manual removal of placenta, removal of retained products of conception, 
assisted vaginal delivery, surgery and blood transfusions 
 
Skilled birth attendant: A Skilled birth attendant is defined by the World Health Organization 
as a person ‘with midwifery skills (for example, doctors, midwives, nurses and medical/surgical 
assistants) who has been trained to proficiency in the skills necessary to manage normal 
deliveries and diagnose or refer obstetric complications 
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CHAPTER ONE 
INTRODUCTION 
This paper has been divided into six different chapters. The first chapter includes the introduction 
and the background that presents the general country profile, the disease burden, the statement of 
the problem and study objectives. In chapter two a review of relevant literature is presented.  The 
third chapter presents the study methodology and data analysis while the forth chapter presents 
the findings; and last but not the least, the discussion of findings, recommendations, and the 
conclusion are presented in chapter five and six.  
1.0. Introduction 
Many women are still dying from complications of pregnancy despite global efforts to reduce 
maternal deaths by 75% by 2015. It was estimated that 287000 women died in 2010, a 47 % 
reduction in maternal mortality rate which is far from the 75% target. Ninety nine per cent of 
these deaths occurred in developing countries, with Sub-Saharan Africa alone contributing to 
56% (161000 deaths) [1]. The major causes of maternal deaths remain the same and they include 
obstetric haemorrhage, sepsis, complications of abortion and eclampsia [2; 3]. Malawi has been 
identified as having one of the highest maternal mortality ratios in Sub-Saharan Africa with a 
ratio of 675 deaths per 100,000 live births in 2010. Pre-eclampsia and eclampsia contributed to 
8% of these deaths [4; 5]. 
Globally, eclampsia contributed to 12% of all maternal deaths [2]. In Africa 9.1% of maternal 
deaths are caused by hypertensive disorders of pregnancy, making them the third leading cause of 
maternal deaths [3].  
Pre-eclampsia and eclampsia not only affect the mothers’ lives, but also their unborn babies as 
well. It is estimated that 26.4% of all neonatal deaths are due to pre-eclampsia and eclampsia [6]. 
Pre-eclampsia is a condition that exclusively affects pregnant women from above 20 weeks 
gestation and is marked by an elevation of blood pressure appearing for the first time in 
pregnancy and the presence of protein in urine. Eclampsia, on the other hand, is the occurrence of 
convulsions in the presence of pre-eclampsia and in the absence of other causes of convulsions 
such as epilepsy [7; 8]. 
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Like most causes of direct maternal deaths, deaths from eclampsia are preventable.  This can 
potentially be achieved through increased accessibility to emergency obstetric care, which can 
effectively be initiated by skilled health care providers at all levels of care [2; 9; 10]. The success 
in the management of pre-eclampsia and eclampsia calls for multi-level efforts. Currently it is 
recommended by World Health Organization (WHO) that management of pre-eclampsia and 
eclampsia be done at referral facilities that have the capacity to deal with adverse complications 
[7; 11; 12; 13]. The primary management of severe pre-eclampsia and eclampsia is delivery of 
the baby and placenta. However, reduction of blood pressure with antihypertensive drugs, and 
prevention and control of convulsions with magnesium sulfate to stabilize the patient are essential 
before effecting delivery [7; 11]. WHO recommends that great efforts be taken at the first level of 
care to stabilize the patient before referral to the secondary or tertiary level of care [2; 11]. 
Stabilization at the first level of care entails establishing and ensuring an open airway and 
prevention of injury to the patient, insertion of intravenous infusions, Foley’s catheter, oxygen 
therapy, and administration of anticonvulsant and antihypertensive drugs depending on the 
condition at hand [11].  Properly stabilized patients have reduced days of hospitalization and a 
high chance of survival [2; 11] 
In Malawi where primary health facilities act as entry points to the formal health care delivery 
system, primary levels are crucial points for successful management of all complications of 
pregnancy, including pre-eclampsia and eclampsia. Pre-eclampsia is a complex disease in which 
several providers at different levels of care interact in an on-going, coordinated manner to 
provide appropriate, effective care. Suboptimal care at any juncture along the continuum of care, 
e.g. at the first level of care, may lead to adverse, even fatal, outcomes which is why it is 
important to have insights on how pre-eclamptic and eclamptic patients are manage at each level. 
Through these insights the healthcare workers themselves and senior management may be able to 
formulate strategies to remedy any problems. Like most developing countries, Malawi has a 
multi-level health care delivery system. The levels consist of primary, secondary and tertiary 
facilities. There are only four tertiary government hospitals and one private tertiary hospital in the 
whole country. Health centres serve as primary level facilities of care, while district hospitals 
basically serve as secondary levels of care [14]. All obstetric complications including pre-
eclampsia and eclampsia are currently managed at secondary and tertiary levels of care. 
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Nevertheless, health centres still remain major entry points for patients into the formal health care 
delivery system [14].  
In Blantyre District, Malawi, pre-eclampsia and eclampsia and all other obstetric complications 
are managed at Queen Elizabeth Central Hospital (QECH). This is one of the tertiary teaching 
hospitals in the southern part of the country. In this district, patients with obstetric complications 
are referred directly from health centres to QECH because there is no district hospital that serves 
as secondary level of care. 
Pre-eclampsia and eclampsia are among the major complications managed at this hospital and are 
among the major direct causes of maternal deaths.  Deaths due to eclampsia almost doubled from 
6.4% to 12.5% between 1999 and 2008[15; 16]. Inadequate pre-referral care at the first level has 
been reported as one of the factors that contribute to maternal mortality at this hospital [15; 16].  
So far, there is limited information on studies conducted to critically evaluate care of patients 
with specific obstetric complications at the primary level. Studies conducted elsewhere and in 
Malawi have focused on the actual management of patients with pre-eclampsia and eclampsia at 
the secondary and tertiary levels and not on the health care providers themselves [ 17; 18; 19; 20; 
21]. 
The few studies that were identified as highlighting health care providers’ views, did not 
necessarily focus on specific conditions like pre-eclampsia and eclampsia; but general 
experiences in the course of the health care providers’ work [22; 23].  
This qualitative study therefore sought to explore first-level health care providers’ perspectives 
on the management of patients with pre-eclampsia and eclampsia before referring them to the 
central hospital. It is hoped that the findings will inform the health authorities on areas that need 
urgent attention as well as inform long-term strategic improvements. 
1.1 Malawi Country profile 
1.1.1 Geography 
Malawi is a sub-Saharan African country located south of the equator. It is bordered to the north 
and northeast by the United Republic of Tanzania; to the east, south, and southwest by the 
People’s Republic of Mozambique; and to the west and northwest by the Republic of Zambia [4]. 
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The country is 901 kilometers long and 80 to 161 kilometers wide. The total country area is 
approximately 118,484 square kilometers of which 94,276 square kilometers are land. The 
remaining area is mostly composed of Lake Malawi, which is about 475 kilometers long and 
delineates Malawi’s eastern boundary with Mozambique [4]. 
Administratively the country is divided into three regions: the Northern, Central, and Southern 
Regions. There are 28 districts in the country. Six districts are in the Northern Region, nine are in 
the Central Region, and 13 are in the Southern Region.  Blantyre district where the study will be 
conducted is located in the southern region of Malawi. (Figure 1)The districts are subdivided into 
Traditional Authorities (TAs), presided over by chiefs. Each TA is composed of villages, which 
are the smallest administrative units, and the villages are presided over by village headmen. 
Malawi has a tropical continental climate with maritime influences. 
Rainfall and temperature vary depending on altitude and proximity to the lake. From May to 
August, the weather is cool and dry. From September to November, the weather becomes hot. 
The rainy season begins in October or November and continues until April [4]. 
1.1.2. Population, socioeconomic and health indicators  
Currently Malawi has a population of 13.1 million, representing an inter-census population 
growth rate of 2.8 percent per year between 1998 and 2008 [4]. The total fertility rate is at 5.7 
children per woman [4]. There are more females 51.4 % than males. Of these women 46 % are in 
the reproductive age group (15-49 years) [4]. Teenage pregnancies remain a public health 
concern considering the complications and deaths associated with such pregnancies. Currently 26 
% of pregnancies are from teenagers. And the median age at marriage is 18 year [4; 5]. 
1.1.3 Economy 
The economy is predominately agricultural with about 80% of the population living in rural 
areas. Agriculture accounts for 30 percent of the gross domestic product (GDP). The 
country’s major exports are tobacco, tea, and sugar. These produce account for approximately 85 
percent of Malawi’s domestic exports [4; 5]. Tobacco is the main agriculture export earner, 
accounting for more than 70% of Malawi’s agricultural exports. Manufacturing and other 
industry and services account for 65% of GDP [14]. And 36 % of the country’s budget is 
dependent on aid [14]. 
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Even though progress report on poverty reduction shows that Malawi is on track to achieving 
millennium development goal number one of reducing extreme poverty by half by 2015, a larger 
proportion of the population (39 %), still live below the poverty line of less than a dollar per day 
[24] 
1.2 Health care delivery system organization 
The WHO defines health systems as “the activities whose primary purpose is to promote, restore 
and/or maintain health” [25]. The main responsibility to provide public health services in Malawi, 
lies with the Ministry of health (MoH), contributing to 63% of all health services.  The other 
contributors include the Christian Health Association of Malawi (CHAM), Ministry of Local 
government (MoLG), private practitioners and Banja la Mtsogolo a nonprofit making 
nongovernmental organization (NGO) which together contribute 37%. There are also informal 
providers such as traditional birth attendants, whose exact number and extent of service provision 
is unknown [14; 26] 
1.2.1 Patient Referral System in Malawi 
A referral system can be described as a set of activities undertaken by a healthcare provider or 
facility in response to its inability to provide the quality or type of intervention suitable to the 
needs of the patient [27].  To be effective a referral must be a two-way process that requires 
coordination and information exchange between the referring facility (usually at the primary care 
level) and the first referral hospital [27]. 
The referral system in Malawi is upstream. Patients from home or other informal health care 
providers such as traditional birth attendants are first seen at the health posts, primary health 
centres or community hospitals [14]. These health facilities, as already pointed out, are entry 
points into the entire formal health care system. At this level, patients are screened and treated for 
their minor illnesses and diseases.  Reproductive health services such as antenatal care, 
uncomplicated deliveries; and family planning are also offered at this level unless they develop a 
complication [14]. Critical cases or complications of pregnancy beyond the primary level’s 
intellectual and infrastructural capacity are referred to the next level which usually is a district 
hospital [14].  
The transportation of patients is facilitated by the primary level staff and sometimes the family 
members. The common transport used is the ambulance which is called from the district hospital 
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(second level of care); because not all primary health centres have ambulances. In case of 
obstetric complications, and on the event of non-availability of a car ambulance, a motorbike 
ambulance has become an alternative in some health centres in order to reduce transportation 
delays [27]. 
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Figure 1: Administrative Map of Malawi 
Map source: www.nationsonline.org                                                                        Blantyre 
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From the secondary level of care facilities, patients are referred to the central hospitals which are 
at a tertiary level and offer specialist treatment. In some cases patients tend to bypass the primary 
health centres to the secondary level of care depending on proximity of the facility. This happens 
mostly in places where CHAM hospitals exist [14]. 
1.2.2 Financing 
The MoH is financed by the government and internal and external donors [29]. Currently all 
MoH public  health services are free at point of delivery, however there are still indirect costs that 
are incurred mainly by the rural population to travel to the facilities due to long distances [29]. 
The total national expenditure on health is limited and is currently at US$ 20 per capita [29]. This 
limitation tends to jeopardize the quality of health services rendered in the health facilities. To 
cover for this deficit, the country greatly depends on foreign aid for most of its health services. 
Currently, donors contribute to 60% on the total health expenditure. However, this dependency 
on foreign aid had negative implications on delivery of maternal and child health services in 
2011; when DFID and other donors suspended aid to the country [30]. 
Prepayment schemes contribute to less than 3% of the health spending. Most of the contribution 
from private sources is obtained from households in the form of out-of-pocket owing to 9 to 12% 
of the expenditure [29]. 
1.2.3 Human resource 
Human resource is very important in provision of health services, and more especially provision 
of reproductive health services which are required to reduce maternal mortality. Despite 
embarking on a 6-year Emergency human resource plan (2005-2010 to increase staffing levels, 
there is still a major crisis of human resources in Malawi. Nurse/ midwives who are very crucial 
in the management of obstetric complications such as eclampsia at the first level facilities are 
very few. Currently there are 4812 nurses, 958 clinical officers, 535 medical assistants and 265 
physicians, excluding the other cadres [31]. It is estimated that there are only 2 physicians and 36 
nurses per 100,000 populations [31]. The crisis is compounded by migration of health workers 
both internally to NGOs and externally to the western countries like United Kingdom and United 
States [14]. There is need therefore for training of more human resources for health to ensure 
adequate staffing at all facility levels of care. This will in turn improve management of patients 
with obstetric complications like eclampsia and help to reduce maternal mortality. 
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1.3. Background 
One of the eight Millennium Development Goals (MDG) adopted at the 2000 Millennium 
Summit was to improve maternal health [32]. The two targets for assessing progress in improving 
maternal health (MDG 5) are reducing the maternal mortality ratio (MMR) by three quarters 
between 1990 and 2015, and achieving universal access to reproductive health by 2015[1]. Even 
though there have been some improvements towards the achievement of this goal, maternal 
mortality still remains unacceptably high in some Sub-Saharan countries, including Malawi [1]. 
A big difference still exists in terms of exposure to risk of maternal deaths between developing 
and developed countries. Currently the life-time risk of dying from pregnancy related 
complication in Sub Saharan Africa is 1 in 39 women as opposed to 1 in 3800 women in 
developed countries [1]. Similarly, Malawi has a high life-time risk of maternal deaths of 1 in 36 
women [1]. High fertility rates, inaccessible health care services, and high HIV prevalence, 
commonly experienced by developing countries, have been implicated for these differences [32]. 
Eclampsia is one of the major causes of maternal and perianal morbidity and mortality [2]. The 
other causes of global maternal deaths include obstetric haemorrhage (25 %), sepsis (15 %), 
complications of unsafe abortion (13 %), and obstructed labour (8%). And eclampsia contributes 
to 12% of these deaths [2].  
Eighty percent (80%) of all causes of maternal deaths including deaths from eclampsia are 
avoidable, through access to essential maternal health care services [33]. However in most cases, 
such health services are inadequate or unavailable in most developing countries [34; 35]. The 
essential services in this case include family planning, antenatal care, and skilled attendants at 
birth, access to emergency obstetric care, postpartum care; and newborn care [33].  
The most emphasized of these services, not disregarding the other services, is access to 
emergency obstetric care [9] which is very crucial for prevention of deaths from eclampsia. 
Emergency obstetric care is a package of life-saving medical interventions that are required to 
treat women with major direct obstetric complications in order to save their lives [9]. The 
interventions include administration of parenteral antibiotics, parenteral oxytocic drugs, manual 
removal of placenta, removal of retained products of conception, assisted vaginal delivery, 
surgery, blood transfusions, and administration of parenteral anticonvulsants [9]. Administration 
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of parenteral anticonvulsant like magnesium sulphate is crucial in preventing convulsions in 
severe pre-eclampsia and in controlling convulsions in patients with eclampsia [9]. 
These interventions are grouped into two; basic and comprehensive, depending on the capacity of 
the facility providing them. A basic emergency obstetric care facility provides all the 
interventions listed above except for blood transfusion and surgery which are done at the 
comprehensive emergency obstetric care facility in addition to all the interventions offered at the 
basic facility [9]. WHO recommends one comprehensive emergency obstetric care (CEmOC) 
facility and 4 basic emergency obstetric care (BEmOC) facilities per 500,000 populations to 
adequately manage complications of pregnancy and save lives [9]. Despite this recommendation, 
Malawi like most developing countries has not been able to achieve the requirement for the basic 
obstetric care mainly due to limited obstetric skills, equipment and supplies [34]. However, due 
to shortage of physicians in Malawi, skilled attendants at the first level facilities of care are 
specially trained to initiate lifesaving procedures for complicated cases like those of eclampsia in 
order to cover up for this shortage[36].  
Classification of facilities into CEmOC and BEmOC has caused misunderstanding in some cases 
leading to health care providers being reluctant to provide emergency care when their facilities 
have not been declared BEmOC [2]. As such, WHO calls upon providers at first level of care to 
stop thinking in terms of which facility is basic or comprehensive, and instead think in terms of 
what could be done at that particular point in time to save a woman with an obstetric 
complication [2]. WHO further states that, the main role of a skilled attendant at the first level of 
care, must be to identify and resolve complications as they arise, in order to avoid degeneration 
into life-threatening emergencies, and she/he must be able to respond to life-threatening 
emergencies when they occur, either directly or by calling on referral level of care [2]. 
1.3.1 Maternal Health in Malawi 
Malawi has one of the highest maternal mortality ratios in Sub- Saharan Africa, currently at 675 
per 100,000 live births [4]. Malawi based on the 1992 mortality ratio of 620 per 100,000 live 
births, as its bench mark for achievement of the MGD 5 [37]. This means that to achieve the 
MDG 5 target by 2015, the current figure has to be reduced to 155 per 100,000 live births; which 
the government concedes to be impossible, considering the limited time remaining. The high 
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mortality is attributed to HIV/AIDS, shortage of human resource, inadequate resources in 
hospitals, gender inequality and traditional practices [4; 37].  
The government’s main efforts to reduce maternal mortality include the development of the 
Roadmap to accelerate maternal mortality reduction. This plan includes strategies to increase the 
availability, accessibility, utilization and quality of skilled obstetric care during pregnancy, 
childbirth and postnatal period at all levels of the health care delivery system; to strengthen the 
capacity of individuals, families, communities, civil society organizations and government to 
improve maternal and neonatal health [38]. Other efforts included the introduction of the 6 year 
Safe motherhood project (1998 to 2004) to reduce deaths and chronic ill health of women as a 
result of childbirth in the southern region of Malawi, the adoption of the Sector wide approach 
(SWAP) in 2004 which ended in the introduction of essential health care package, and the 6 year 
Emergency Human Resources Plan which aimed at improving human resource retention and to 
increase the staffing levels [31; 38]. The essential health care package at the first level facility of 
care  for maternal and neonatal health includes focused antenatal care, intrapartum care with 
BEmOC services of which includes management of pre-eclampsia and eclampsia, and newborn 
care and postnatal care[38]. 
 1.3.2. Malawi’s progress on MDG 5 
According to the Millennium Goal progress report for 2012, MDG 5 is the only millennium goal 
that is lagging behind and is far from being attained by 2015[32]. Using the indicators for 
assessing improvement in maternal health which includes the maternal mortality ratio, antenatal 
coverage and proportion of births attended by skilled attendants, the report indicated that there 
has been some progress towards  achieving the MDG 5, though little to have a strong impact [32].  
The MDHS report 2010 also indicated an antenatal coverage of 95%, slightly lower than   that 
reported by MICS 2006, (97%), though the difference is not statistically significant [4;39].  
Among other things, underutilization of reproductive health services was attributed to long 
distances and lack of transport [4]. There was a great improvement in skilled attendance at birth 
with 71 per cent of births being assisted by skilled attendants. This was a greater increase from 
54% skilled attendance reported by MICS study in 2006[39]. There has been a marginal increase 
in contraceptive uptake from 41% to 46%. Maternal mortality ratio is currently at 675 per 
100,000 live births, a decrease from 984 which was reported in 2004 [4]; and 8% of these deaths 
are due to eclampsia [5].  Although some progress has been made to improve maternal health in 
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Malawi, there are still some challenges that need to be addressed. One of the challenges crucial to 
reduction of maternal mortality due to eclampsia is the issue of accessibility to emergency 
obstetric care. Currently, functional basic emergency care facilities are very few [34], which calls 
for more efforts to improve the situation. Other efforts also need to be considered to reduce 
maternal mortality such as focusing on improving the quality of management at first level 
facilities. Apart from well-established screening activities for prevention of mother to child 
transmission of HIV [4], complications like pre-eclampsia which can easily be detected through 
antenatal care have not been well targeted. There is need to intensify interventions that target 
individual complications like pre-eclampsia too, in order to prevent progression to eclampsia 
which kills mothers. 
 
This study therefore, sought to explore perspectives of first-level healthcare providers on the 
management of patients with pre-eclampsia and eclampsia before referring to the tertiary level of 
care. 
1.4 Problem statement 
Conforming to the WHO recommendations on management of patients with obstetric 
complications before referral [2], and being determined to reduce maternal mortality, the MoH 
recommends that patients with obstetric complications must receive life-saving treatment at the 
first level of care in order to stabilize them before referral for further management at the next 
level [11; 13] in order to reduce the proportion of patients’ hospitalization and deaths from 
obstetric complications [2]. 
Despite a national recommendation to stabilize critical patients before referral, Queen Elizabeth 
Central Hospital (QECH) as a referral continues to receive patients with eclampsia and other 
obstetric complications in poor condition from some of its surrounding health centres and private 
clinics. Lack of life-saving obstetric care at the health centres has resulted in increased maternal 
and perinatal mortality [16]. 
 Apart from blaming the first-level healthcare providers for the poor outcome of patients at the 
referral hospital, there is a paucity of information on studies  or quality assurance activities done 
to understand or appreciate management from the healthcare providers’ point of view. Some 
studies have shown that giving health care providers a voice tends to help them to reflect on their 
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own practices and attitudes and creates room for instant improvements [23]. This study sought to 
explore first level healthcare providers’ perspectives on the management of patients with pre-
eclampsia and eclampsia before referring them to the next level of care in order to identify gaps 
and barriers to the management of patients with pre-eclampsia and eclampsia. 
1.4.1 Rationale 
Pre-eclampsia and eclampsia still kill mothers in pregnancy and child birth, and yet these deaths 
can be prevented. Early detection and prompt intervention at the first-point of contact is crucial in 
averting these deaths. WHO recommends that emergency life-saving care be given to patients at 
the first contact prior to referral in order to increase the chance of survival at the referral facility 
[2; 11]. However, studies previously investigating pre-eclampsia and eclampsia were conducted 
at secondary and tertiary levels of care despite the fact that patients make their first contact with 
the formal health system at the primary level.  These studies also had much focus on the care 
provided and not the providers of care themselves [17; 18; 19; 20; 21]. The findings of the study 
will help to inform and create awareness of the context in which first-level healthcare providers 
manage patients with pre-eclampsia and eclampsia.  The information will also in turn help the 
health authorities devise strategies for improving the quality of care at the first level of care in 
order to reduce maternal and perinatal morbidity and mortality from pre-eclampsia and 
eclampsia. Moreover the findings will help first-level healthcare providers become aware of their 
own practices, strengths and weaknesses in the management of pre-eclampsia and eclampsia. 
Having insight into the perceptions of the health workers will enable those involved in training 
health workers to develop effective refresher courses that will be based on real challenges in the 
management of pre-eclampsia and eclampsia complications. Lastly, the research will also help 
training institutions improve current curriculum with regards to the management of pre-eclampsia 
and eclampsia.  
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1.5 Objectives 
Main objective:   
To explore first-level healthcare providers’ perspectives on the management of patients with pre-
eclampsia and eclampsia before referral to the hospital. 
Specific objectives 
1. To assess how first-level healthcare providers in Blantyre manage patients of pre-
eclampsia and eclampsia before referral to the second or third level of care 
2. To assess barriers to proper management of patients with pre-eclampsia and eclampsia at 
the first level of care 
3. To obtain suggestions for the improvement of the management of patients with pre-
eclampsia and eclampsia at the first level of care 
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CHAPTER TWO 
LITERATURE REVIEW 
2.0 Introduction 
Several studies have been reviewed in relation to the proposed study; both quasi and systematic 
reviews. The focus of most studies on pre-eclampsia and eclampsia was at secondary and tertiary 
levels of care and not much was found that was done at the primary level of care which was the 
area of interest in this study. In this chapter a presentation of literature on what is known on 
management of pre-eclampsia and eclampsia will be done. However, due to paucity information 
on qualitative studies done at the first level facility of care, a few studies that were found that 
highlighted health care providers’ views on quality of care in general were included in this 
review.  
2.1 History 
The history of pre-eclampsia and eclampsia dates back to the ancient times of Hippocrates in the 
4
th
 and 5
th
 century. Although not termed as pre-eclampsia and eclampsia, the physicians at that 
time documented about it as a presence of headache accompanied by heaviness and convulsion 
during pregnancy and observed that such a presentation was critical for the patient. It was not 
until 1619 when the term eclampsia was first used in Varandaeus’ treatise on gynecology [40]. 
Throughout the centuries physicians have been trying to explain the cause of pre-eclampsia and 
eclampsia. Some explanations included the belief that eclampsia was nature’s way of  trying to 
free the  organism of any morbid element; or that the  expanded pregnant  uterus increased 
pressure on the descending blood vessels  and  the increased  pressure in turn led to regurgitation 
of blood in the head ,resulting in an overload of the cerebral vessels and subsequent 
convulsions[40]. Basing on these theories, the treatment of eclampsia involved bloodletting to 
ease the pressure, cold water splashing, warm baths, and use of opiates and hastening of delivery 
[40].  
The causation theories that are used now are based on the theory that was developed in 1960. The 
theories relate the development of pre-eclampsia to the abnormal placentation and restricted 
blood flow to the placenta [40]. 
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2.2 Incidence and mortality  
Pre-eclampsia remains one of the leading causes of maternal and perinatal morbidity and 
mortality worldwide. Every year 8 % of all pregnancies are complicated by pre-eclampsia and 
eclampsia worldwide [12; 41].The incidence ranges from 3% to 7% for nulliparous and 1% to 3% 
for multiparas [41]. Eclampsia on the other hand, complicates one in 2000 deliveries in the 
United Kingdom and in low- and middle-income countries it complicates between one in 100 and 
one in 1700 deliveries [42]. Every year, 63000 women die from eclampsia which is 
approximately 12% of all maternal deaths (2). Eighteen (18 %) of all maternal  deaths in 
developing countries are due to hypertensive disorders of pregnancy which includes  pre-
eclampsia and eclampsia (43). In Africa 9.1% of maternal deaths are caused by hypertensive 
disorders of pregnancy, making them the third leading cause of maternal deaths [3]. 
In some African countries like South Africa, pre-eclampsia and eclampsia affects 12% of all 
pregnancies and are the second common causes of maternal deaths [44). A population based 
inquiry on maternal deaths for the period of 1999 to 2001, revealed that pre-eclampsia and 
eclampsia contributed to 83 % of the 622 deaths from hypertensive disorders of pregnancy [44].  
In Malawi, pre-eclampsia and eclampsia are the fourth highest causes of maternal deaths. Even 
though there is paucity information on the incidence and prevalence rates, the mortality rate is 
estimated at 8% of all maternal deaths [5]. 
Institutional based mortality reports on pre-eclampsia and eclampsia in Malawi range from 4 % 
to 17 % of all maternal deaths [15; 45].  
At Queen Elizabeth Central Hospital (QECH), one of the tertiary referral hospitals in the southern 
region of Malawi, deaths from pre-eclampsia and eclampsia almost doubled between 1999 and 
2008 from 6.4 % to 12.5% [15; 16].  
2.3. Pathophysiology 
Until now, the cause of pre-eclampsia is still unknown; however several hypotheses have been 
developed over the years trying to explain what goes on in pre-eclampsia. These hypotheses 
include immunological factors and placentation factors. 
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2.3.1 Immunologic Factors in Pre-eclampsia 
The first hypothesis states that there exists maternal intolerance to paternally derived placental 
and fetal antigens. This maternal-fetal immune maladaptation is characterized by defective 
cooperation between uterine natural killer (NK) cells and fetal human leukocyte antigen (HLA)-
C, which results in histologic changes similar to those seen in acute graft rejection. It is 
hypothesized that the endothelial cell dysfunction that is characteristic of pre-eclampsia may be 
partially due to an extreme activation of leukocytes in the maternal circulation, and this is 
evidenced by an up regulation of type 1 helper T cells [41]. 
2.3.2 Placentation factors 
During normal pregnancy, the villous cytotrophoblast invades into the inner third of the 
myometrium, causing the spiral arteries to lose their endothelium and most of their muscle fibers. 
These structural modifications are associated with functional alterations, such that spiral arteries 
become low resistance vessels, and thus less sensitive, or even insensitive, to vasoconstrictive 
substances. The reduced resistance in the spiral arteries greatly facilitates blood flow to the 
placenta compared with other areas of the uterus [8; 41].  
 
In pre-eclampsia however, this process appears to be defective, leading to untransformed narrow 
thick blood vessels which in turn lead to hypo perfusion and ischemia of the placenta. The 
defective process in this case is attributed to the failure of cytotrophoblast cells to express the 
adhesion molecules necessary for normal remodeling of the maternal spiral arteries [8; 41]. The 
ischemic state of the placenta is believed to trigger a widespread activation/dysfunction of the 
maternal vascular endothelium which results in enhanced formation of endothelin, thromboxane, 
and superoxide, increased vascular sensitivity to angiotensin II, and decreased formation of 
vasodilators such as nitric oxide and prostacyclin. The endothelia abnormalities in turn cause 
hypertension by impairing renal function and increasing total peripheral resistance. [8; 41]. 
2.4. Screening and diagnosis of pre-eclampsia 
Screening for pre-eclampsia is an ongoing process during prenatal, intrapartum and postpartum 
period and must actively be done by health care providers at all levels of care. The screening 
takes a form of observation, history taking to identify at risk women, blood pressure checking and 
laboratory tests. 
 
18 
 
2.4.1 Risk factors 
Several factors are known to be associated with development of pre-eclampsia at antenatal 
booking and must always be taken into account at first contact with the pregnant woman. A 
systematic review of controlled cohort studies by Duckitt and Hurrington (2005); indicates that 
age, parity, previous pre-eclampsia, family history of pre-eclampsia, multiple pregnancy, pre-
existing medical conditions such as Insulin Dependent Diabetes (IDDM) and chronic 
hypertension  are associated with development of pre-eclampsia[46]. 
 
In their systematic review, Duckitt and Hurrington found that women aged 40 and above had 
almost twice the risk of developing pre-eclampsia, whether they were primiparous or 
multiparous, without controlling for other factor like pre-existing chronic disease such as 
hypertension or diabetes.  The researchers reported that young age did not seem to affect the risk 
of developing pre-eclampsia, whichever cut off age was used [46].  
 
On the contrary, Pal et al in 2011, in their cross sectional institution study to analyze the 
incidence of eclampsia, types of eclampsia, socio demographic characteristics of the subjects, 
mode of delivery, maternal and perinatal outcomes over a ten year period; and to evaluate the 
utility of different management protocols followed in the hospital to treat pregnancy with 
eclampsia at Burdwan tertiary teaching hospital, in Bangladesh, found that 6.97 % of the 5991 
eclamptic patients that were admitted during this period were less than 20 years of age as 
opposed to 3.17 % who were above 35 years [20]. This might suggest young age to be strongly 
associated with pre-eclampsia and eclampsia in this particular study. This might also mean that 
all pregnant women are potentially at risk of developing these conditions; as such they must all 
be given the same attention.  However, this was a finding from one cross sectional study, as 
opposed to the systematic review. Knowledge of risk factors is important for health care 
providers; in order for them to be able to identify women who may potentially be at risk of 
developing these conditions. 
2.4.2 Detection and diagnosis of pre-eclampsia 
The main form of detecting women with pre-eclampsia is through measurement of blood pressure 
at every antenatal visit, during labour and during postpartum. There is a great association 
between lack of antenatal care and development of severe pre-eclampsia and eclampsia. A study 
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done by Tukur et al, in 2010  to evaluate the effect of the introduction of magnesium sulphate for 
the management of eclamptic seizures on maternal and fetal indices at Aminu Kano Teaching 
Hospital [AKTH], in Nigeria, between 2005 and 2007, the researchers found that 87% of the 
131eclamptic patients were unbooked for antenatal care [17]. Similar findings were also reported 
by Liu et al, 2005, in their retrospective study comparing referral and non-referral hypertensive 
disorders during Pregnancy in an analysis of 271 cases at a tertiary hospital [47]. In this study 
researchers reported that 26% of the cases never received antenatal care and were significantly 
associated with severe pre-eclampsia, HELLP syndrome, low birth weight and low Apgar score 
as compared to those who attended antenatal care. This could be attributed to the fact that those 
women who received antenatal care had a chance of their high blood pressures being detected and 
treated at an early stage as opposed to those women who did not receive any antenatal care. 
 
This makes it imperative for health care providers to check and monitor blood pressures of every 
pregnant woman during antenatal visits. This would help them to detect women with the 
condition at an early stage and to refer them for specialist antenatal care or to immediately 
intervene if patient already at specialist level of care. 
 
 Confirmation of diagnosis of pre-eclampsia is done through urine test for presence of protein 
(proteinuria). This test is done if blood pressure is found to be high and the gestation age is above 
20 weeks [6, 13; 41]. Proteinuria in this case is defined as protein of 300 mg per day or more or 
30 mg per mmol in a single 24 hour urine specimen or 1+ dipstick [6; 12; 41]. The  test for urine 
protein  can be done at all facility levels using simple  protein dipsticks, which are specifically 
manufactured  for this purpose and are user friendly [12; 13].  
 
On the other hand, diagnosis at   secondary and tertiary level facility  may include the following 
laboratory tests depending on availability of those resources; a complete blood count with 
platelets, hepatic tests  to identify potential HELLP syndrome;  a blood smear to test for 
schistocytes; renal function tests to rule out  acute renal failure or uremia e; 24-hour proteinuria; 
prothrombin, activated thrombin time, and fibrinogen (microangiopathic hemolytic anemia); 
blood group; and irregular antibody screening[6;41].   Sonography of the fetus is recommended 
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among at risk groups in order to detect any growth restriction that is usually observed in pre-
eclampsia if the service is available [6; 41]. 
 
Knowledge of such laboratory tests is crucial because deviation entails severity of disease. It also 
helps physicians to differentiate pre-eclampsia from other forms of hypertension in pregnancy to 
ensure appropriate treatment. 
 
2.4.3 Classification of pre-eclampsia 
Pre-eclampsia can be classified as mild and severe [6; 12; 13].  
 Mild pre-eclampsia 
Preeclampsia is termed mild when a woman has two measures of diastolic blood pressure 90–110 
mm Hg, 4 hours apart, after 20 weeks gestation and has proteinuria of up to 2+. Mild pre-
eclampsia usually does not exhibit any symptoms [6; 11; 12; 13]. However, the danger is that it 
can progress to severe pre-eclampsia, then eclampsia within a short period of time [13]. As such, 
health care providers need to be alert when a woman presents with mild pre-eclampsia. 
 
 Severe pre-eclampsia 
Pre-eclampsia is said to be severe when a woman presents with a diastolic blood pressure 
of110mm Hg or more after 20weeks gestation and has proteinuria of 3+ or more [13]. As 
opposed to mild pre-eclampsia, a woman with severe pre-eclampsia may present with persistent 
headache of an increasing frequency; and which is not relieved by regular analgesics; blurred 
vision, oliguria (passing less than400 mL urine in 24 hours), epigastric pain, pulmonary edema 
and severe swelling of hands, face, or feet of sudden onset [6;11;12; 13]. Being aware and 
recognizing such signs and symptoms are crucial for prompt detection, better management and 
for good prognosis of patients. It is imperative therefore that all health care providers observe and 
be aware of these signs and symptoms in order to promptly and effectively manage women who 
present with severe pre-eclampsia. 
 
 Eclampsia 
Eclampsia is the major complication of pre-eclampsia, and is described as the occurrence of 
convulsions in the presence of pre-eclampsia and in the absence of other causes of convulsions 
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such as epilepsy [7].  The convulsions resemble tonic-clonic epileptic fits and reoccur in rapid 
sequence. They may occur regardless of severity of blood pressure and are difficult to predict 
because they can occur without warning signs such as headache or visual disturbances. A woman 
may remain in coma for a few minutes or hours following a convulsion [13]. Both pre-eclampsia 
and eclampsia may also occur after delivery. It is estimated that 25% of cases of eclampsia 
actually occur after delivery; therefore it is important that health care providers continue blood 
pressure monitoring on women after delivery [13].  Other complications of pre-eclampsia include 
pulmonary edema, renal failure, disseminated intravascular coagulation (DIC), placenta 
abruption; haemolysis elevated liver enzymes and low platelet count (HELLP) syndrome [12].  
Complications for the baby may include preterm births, intrauterine growth restriction and 
deaths, which may be secondary to early termination of pregnancy due to severity of the 
condition [12].  
 
2.5 Management of pre-eclampsia and eclampsia 
Due to its gravity, management of pre-eclampsia and eclampsia is recommended to be done at a 
health facility with the capacity to deal with the complication [7; 11]. It is however, 
recommended that stabilization of patients be initiated at the first level of care before referral to 
the next level of care in order to increase patients’ chance of survival [2; 48].  
 
2.5.1 Prevention of pre-eclampsia 
Prevention of pre-eclampsia is difficult due to lack of known cause. However, focus of 
prevention is on early detection of pre-eclampsia in order to prevent its progression to eclampsia. 
It is recommended therefore that close monitoring of both in hospital or outpatient be done [13]. 
Other strategies to prevent progression to eclampsia  include  use of antihypertensive therapy to 
keep maternal blood pressure to normal or safe ranges, timely delivery, and prophylactic use of 
magnesium sulphate during labour and in immediate postpartum in those considered to have 
severe pre-eclampsia[5; 49]. WHO also recommends supplementation of calcium at 1.5-2.0grams 
and aspirin 75mg per day during pregnancy for women at risk of developing pre-eclampsia [7]. 
Skilled attendants at birth are very important in order to monitor, detect and manage pre-
eclampsia and eclampsia promptly before it progresses to a life threatening state [7; 49]. 
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2.5.2 Treatment 
The primary treatment of severe pre-eclampsia and eclampsia is delivery of the baby and 
placenta; however reduction of blood pressure with antihypertensive medicines, and prevention 
and control of convulsions with magnesium sulfate to stabilize the patient is essential before 
effecting delivery [7; 13]. The delivery of the baby is however determined by severity of the 
disease and the duration of pregnancy [13]. 
 
  Control of blood pressure 
Following a systematic review of 17 Cochrane reviews and 2 systematic reviews by WHO 
steering group which included staff from WHO Departments of Reproductive Health and 
Research, Making Pregnancy safer, and Nutrition for Health and Development and two external 
experts, 2011; WHO recommends use of nifedipine, hydralazine, and labetalol for reduction of 
blood pressure in pre-eclampsia and eclampsia among other recommendations [7]. Authors of 
other clinical reviews have also recommended the same antihypertensive drugs [12; 41].  
However, these drugs are only recommended for treatment of severe pre-eclampsia.  
 
Mild pre-eclampsia on the other hand is managed expectantly by monitoring blood pressure and 
urine protein twice a week on outpatient basis if patient stays close to health facility and daily 
monitoring if patient is admitted [13].  Delivery is expedited if patient presents at 37 weeks 
gestation or regardless of gestation if condition worsens and is affecting the condition of the 
unborn baby [13].  On the other hand, delivery is recommended within 24 hours and 12 hours for 
severe pre-eclampsia and eclampsia respectively [13]. 
 
  Prevention and control of convulsions 
Magnesium sulphate (MgSo4) is a drug of choice for prevention and control of convulsions in 
pre-eclampsia and eclampsia [7]. In a Cochrane review of 15 randomized trials, which included 
11,444 women, with an objective to assess the effects of MgSo4, and other anticonvulsants, for 
prevention of eclampsia, Duley et al, 2010, found that MgSo4 halves the risk of eclampsia and 
that it probably reduces risk of maternal death. However, the authors found no clear difference in 
serious maternal morbidity and no clear difference in stillbirths or neonatal deaths [42]. 
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In a hospital based prospective cross sectional study done in Assiut University Hospital, in Egypt, 
to evaluate the protocol used for management of eclampsia at this hospital, the researchers found 
that MgSo4 was able to control convulsions in 98.1% of the 1998 eclamptic women who were 
recruited in the study from 1990 to 2010; and there was only 4% mortality [18].  These findings 
indicate a much higher efficacy of MgSo4 than that reported by the Cochrane review above. 
However, the difference could be attributed to the differences in the characteristics of the subjects 
as well as study methodologies. The Cochrane review used randomized clinical trials and focused 
both on management of severe pre-eclampsia and eclampsia, while the Egypt study focused only 
on eclampsia and there were no controls. Nevertheless, both reports support the use of MgSo4 for 
control of convulsions.  
 
A similar study was done in south eastern Nigeria to determine the effect of introducing MgSO4 
on the maternal and perinatal outcomes of severe pre-eclampsia in Enugu, South eastern Nigeria. 
This was a retrospective study of all cases of severe pre-eclampsia managed at the University of 
Nigeria Teaching Hospital Enugu (UNTH), Nigeria, from 1 January 2005 to 31 December 2008 - 
2 years before, and 2 years after the introduction of MgSO4. The researchers found that none of 
the patients in the MgSO4 group had seizures after the commencement of the drug, while one 
woman from the diazepam group had an episode of tonic clonic seizures. Another interesting 
finding in this study was the reduced hospital stay among women who received MgSo4 as 
opposed to those who got diazepam, 11% versus 35% respectively. As opposed to the Egypt 
study, there were no maternal deaths in either of the groups in this study. This however, might be 
attributed to the sample sizes in these two studies and also study designs. But, one thing is clear 
in both studies, the support for use of MgSo4. On the part of perinatal outcome, the researchers 
found that there was a tendency of low 1 minute Apgar score in babies born from women who 
received diazepam, but the difference was not significant [50].  
 
There was limited information on qualitative studies on management of pre-eclampsia and 
eclampsia elsewhere; as such, studies that seemed close to this current study were reviewed. 
A study was done by Hassan-Bitar and Wick in 2006; to assess the quality of maternity care in a 
large Palestinian referral hospital, as a first step in developing interventions to improve childbirth 
care for mothers and newborns. The study used both quantitative and qualitative methods for data 
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collection. Data was collected using observations, semi-structured interviews and, in-depth 
interviews with 31 maternity care providers working at the hospital [23]. This was complemented 
with informal discussions with health care providers, cleaners, secretaries, clerks, administrators, 
managers and women to confirm the observed practice. The researchers conducted semi-
structured interviews with all women who gave birth at the hospital regardless of the mode of 
delivery to learn about their birth experience and their interactions with care providers as well as 
their experience with postnatal care. The results indicated that there was a great degree of 
suboptimal childbirth care which was attributed to severe understaffing of midwives, insufficient 
supervision, and lack of skills, stressful environment, financial insecurity, insufficient supplies 
and poor attitudes. 
Another similar study was a qualitative study that was done in Tanzania by Manongi et al in 2004 
to explore the experiences of health workers working in the primary health care facilities in 
Kilimanjaro Region, Tanzania, in terms of their motivation to work, satisfaction and frustration, 
and to identify areas for sustainable improvement to the services they provide[22]. The study was 
done in three districts of Tanzania focusing on staff working in government primary health 
centres. Six focus group discussions were conducted to collect data with the aid of a semi-
structured interview guide that was developed following a pilot study. The participants in the 
focus groups included nurses and clinicians and the discussions were conducted separately. Two 
focus group discussions were conducted in each district. Participants in the study were randomly 
selected from a health worker list from dispensaries and health centres [22]. 
 
Findings indicated that the health care providers lacked supportive supervision, feedback from 
the referral facility, performance appraisal, career development and transparent promotion. They 
also expressed need for inter-facility exchange for commonly referred conditions in order to 
improve their provision of care [22]. Despite the fact that these two studies did not specifically 
look at management of pre-eclampsia and eclampsia, they both focused at health care providers 
though at different facility levels. The methods therefore were useful in the designing of this 
study. 
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2.6 Management of pre-eclampsia in Malawi 
Malawi was one of the countries which participated in a double blinded randomized placebo 
clinical trial called Magpie between 1998 and 2001. The aim of the study was to determine 
whether women with pre-eclampsia and their babies benefit from the use of MgSo4. There were 
10141 women who were randomized in this trial. The results indicated that MgSo4 halves the 
risk of eclampsia, and probably reduces the risk of maternal death. The results also indicated that 
there did not appear to be substantive harmful effects to mother or baby in the short term [51]. 
Despite this fact, there was scarcity of other studies done in Malawi to specifically follow up on 
the Magpie trial or any study focusing on the management of preeclampsia; except for a study 
that was done at Bwaila referral hospital in the central region of Malawi. The study was done to 
evaluate the effect of monitoring and treatment charts on the management of eclampsia at this 
hospital. The researchers introduced a monitoring and treatment chart for patients with eclampsia 
in 2006. They compared charts of patients managed in 2005 before introduction of charts (n=89) 
and of patients managed in 2007 after introduction of the charts (n=75). The researchers found 
that there was improved care which might also have reduced caesarean sections from 87% to 
33% as more women underwent induction after stabilization [21]. 
 
However, Malawi follows the WHO guideline for the management of pre-eclampsia and 
eclampsia which was introduced in the country in 2004 [21]; as such it recommends use of 
MgSo4 and antihypertensive drugs in the management of preeclampsia and eclampsia. All cases 
of pre-eclampsia and eclampsia are managed at secondary and tertiary levels, in this study at 
QECH referral hospital; however there is a big role that the first level facilities play before the 
patients are referred to the hospital [7; 13].  
2.6.1The role of first-level facilities in the management of pre-eclampsia and 
eclampsia 
First levels are entry points to the formal health care delivery system; as such they are crucial to 
the survival of women with complications of pregnancy like pre-eclampsia and eclampsia. In 
Malawi, the management of pre-eclampsia and eclampsia at this level is based on WHO’s best 
practice guidelines for midwives at  first  level facility and  according to guidelines for managing 
complications in pregnancy and childbirth[11; 13]. 
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 Problem detection 
The first responsibility of health care providers at the first level facility is to be able to detect 
women who present with the condition. This can be achieved by screening all pregnant women at 
every antenatal visit. The screening involves history taking on the first visit and blood pressure 
check on every antenatal visit. Checking and comparing previous and present blood pressure 
readings to identify any elevations; and also checking on rapid excessive weight gains in women 
occurring within a short period of time. If the blood pressure reading is high, the woman needs to 
be given some time to rest before a recheck of the blood pressure. This helps to rule out other 
factors that might elevate the blood pressure. Danger signs like headache, blurred vision and 
epigastric pain must be rule out by asking the woman. The health care provider is also supposed 
to check urine protein using protein dipsticks to confirm diagnosis [11].  
 Classification and Management 
The second responsibility is to classify the blood pressure according to severity.  If patient is 
found with mild pre-eclampsia, the patient is supposed to be counseled on the change of birth 
plan in terms of place of delivery, and must be referred to the hospital [11].  
If the woman is diagnosed with severe pre-eclampsia, she is supposed to be given a loading dose 
MgSo4. She must also receive appropriate antihypertensive drugs if diastolic is above 110mmHg, 
and refer to the hospital urgently [11]. 
Blood pressure readings of diastolic 90mmHg and above with no protein in urine are grouped as 
hypertension. As such the woman must be advised on reduced workload and rest. The woman 
must also be told to immediately seek medical care if she observes any of the following danger 
signs; severe headache, blurred vision and epigastric pains. The woman needs to be reviewed 
after a week and if blood pressure still persists refer to hospital [11].  
 Eclampsia 
Eclampsia regardless of level of facility must be treated as an emergency. Guidelines on essential 
practice and on managing complications of pregnancy and childbirth[11], which are also similar 
to guidelines for basic maternal and newborn care by JIEPGO [11; 13; 48], recommend that 
patients presenting with severe pre-eclampsia and eclampsia  must be  stabilized according to the 
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gold standard for management of these conditions[Appendix I ]. It is imperative therefore that 
health care providers at the first level facility be conversant with these guidelines in order to 
efficiently managed patients with severe pre-eclampsia and eclampsia. 
 
2.7 Complications of pre-eclampsia and eclampsia 
Apart from eclampsia which has already been described in the a bove sections, pre-eclampsia  
may also complicate to into stroke,  renal failure,  pulmonary oedema, haemolysis, elevated liver 
enzymes, and low platelets (HELLP syndrome), and disseminated intravascular coagulopathy 
(DIC) [12;13]. Complications for the baby may include preterm births, intrauterine growth 
restriction and deaths, which may be secondary to early termination of pregnancy due to severity 
of the condition[12]. 
 In summary, this literature review has helped the researcher to understand what other studies 
have done in relation to the current study. It has been observed from the literature review that 
eclampsia is one of killers in childbirth. It has also been observed that due to lack of known cause 
of pre-eclampsia prevention is difficult; hence efforts must be directed towards prevention of its 
progression to eclampsia in order to prevent deaths. However, the studies in this literature review 
were quantitative and concentrated much on secondary and tertiary level facilities of care, 
creating a transitional care gap between the first level facility and the other levels. Except for a 
few studies, focus of the studies on pre-eclampsia and eclampsia has been on the treatment of the 
patients other than the providers of the treatment themselves, which in this case are the health 
care providers. Therefore, there is need for studies to be done at the first level facilities in order to 
link management of patients with pre-eclampsia and eclampsia between the two facility levels, 
thereby improving outcome of patients; hence the purpose for the current study. 
2.8Conceptual framework of this study 
It has emerged from the preceding literature that management of pre-eclampsia and eclampsia 
depends on health workers having the correct knowledge about these conditions. They need to 
recognize and diagnose the conditions early enough and provide the first level tests and 
treatments. Since eclampsia can be fatal, health workers are expected to refer such patients to a 
hospital immediately. This process requires that patients arrive at the health centre in good time 
and health workers make correct judgment about the conditions. Finally, the first level health 
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services must be in line with the expectations and treatment thereafter at the referral hospital. In 
other words, the health workers at the health centres need to be supervised by those in hospitals 
and also they should get the correct feedback on the type and quality of first level services they 
are providing to patients so that they can improve. 
 
The first level health services also depend on the availablility of equipment for diagnosing the 
conditions and the drugs for containing the conditions. Life is also saved if the referral is made 
effectively and efficiently without delay and with all the support the patients would require. This 
conceptual framework can be illustrated as in Figure2. 
           
          STAGE I: AT HOME 
 
 
 
           STAGE II: 
           HEALTH  
           CENTRE 
 
 
 
 
         STAGE III: REFERRAL  
           HOSPITAL  
 Figure 2:  
 
Figure 2 brings to the surface important concepts which will be the focus of this study. These 
include knowledge of pre-eclampsia and eclampsia, procedure for assessing the conditions, how 
to manage the two conditions and referral process of patients presenting with these conditions.  
 
The conceptual framework is also based on the fact that pre-eclampsia and eclampsia 
management skills are essentially those abilities that help to ease the complications arising from 
A patient at home 
 
Pre-eclampsia  
 
Drugs administered 
 
Referral to hospital 
 
Eclampsia 
Feedback 
Diagnosis of the condition 
Attends antenatal clinic 
 
Figure 2: framework for managing pre-eclampsia and eclampsia conditions 
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pregnancy and competence in health care providers as they face the realities of life. Management 
skills are also regarded as professional skills required by all health workers at all levels to 
function confidently and competently with themselves, with other professional and with the 
patients.  
 
From the literature reviewed in this study, management skills have been categorized into five 
broad areas:  
 
Stage I: at home 
1. the patient understanding of the need to seek health care during pregnancy, also for 
condition and showing up at the health centre for help: these include knowledge and beliefs 
about pregnancy related conditions within the cultural context 
 
Stage II: at the first level care 
2. The skills of knowing and identifying the pre-eclampsia and eclampsia patients. These 
include signs and symptoms of the conditions  
3. The skills of diagnosing, treating and controlling the conditions; these include: conducting 
test and administering drugs to avoid convulsing and to stabilize the situation 
4. The skills of arranging for referral to hospital include: stabilizing the patient, arranging for 
transport, and escorting the patient,  
 
Stage III: at the referral hospital 
5. The skills of pre-eclampsia and eclampsia patients by the health workers at the referral 
hospital including feedback 
 
The management skills can be utilized in prevention of pregnancy complications and thus 
improving safe motherhood. Therefore for the purpose of this study; the management is used to 
refer to both professional and practical use of knowledge and resources by the health workers at 
the first level and referral hospital. These could be demonstrated by the methods used in 
identifying, testing, treating and referring patients with pre-eclampsia and eclampsia. 
Applications of management skills at various levels of health care provision by the health 
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workers at both first level and referral level indicates their awareness of the criticality of  pre-
eclampsia and eclampsia.  
 
The factors that could affect the management of pre-eclampsia and eclampsia will be explored 
through the following themes: (a) the professional knowledge and practices of health workers 
demonstrated in the management of patients with pre-eclampsia and eclampsia; (b) the treatment 
of severe conditions; (c) the referral process; (d) supervision and feedback from the superiors and 
referral hospitals. 
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CHAPTER THREE 
METHODOLOGY 
3.0 Introduction 
 
This chapter presents a detailed process of methods used in data collection. A detailed 
explanation of data analysis is also presented. The sections in this chapter include study design, 
study setting, data collection, data analysis, trustworthiness, dissemination and ethical 
consideration. 
3.1 Design 
 
This is a qualitative in which the researcher used review of records, semi- structured interviews, 
focus group discussion and participant observation to collect data. Qualitative research is a form 
of social enquiry that focuses on the way people interpret and make sense of their experience and 
the world in which they live. It seeks to understand a given research problem or topic from the 
perspectives of the population it involves [52; 53]. As opposed to a quantitative approach which 
commonly uses rigid and structured methods such as questionnaires, surveys, structured 
observations and closed questions with predetermined answers, qualitative methods are flexible. 
Use of open-ended questions in semi-structured interviews and focus group discussion allows full 
expressions to be given by the respondent; in other words the participant assumes the expert 
position [53]. In this study, a qualitative approach was used to allow healthcare providers to 
express their views and experiences as observed and lived in their daily life world. It gave them a 
chance to reflect on what they do in their natural world when they receive a patient with pre-
eclampsia and eclampsia; other than assuming and limiting them to preset answers as is 
commonly done in quantitative methods.  
 
In this study within method and data triangulation were used. Triangulation is the process by 
which several methods such as data sources, theories, or researchers are used in the study of one 
phenomenon [54]. Within or intra-method triangulation uses different strategies to collect data 
but stays within a single paradigm [52; 54]. This study used semi-structured interviews, non-
observation, and focus group discussions in its methods triangulation. Data triangulation uses 
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multiple data sources based on time, space and person with similar foci to obtain diverse views 
about a topic for the purpose of validation and completeness [52; 54]. In the current study space 
and person triangulation were used. To triangulate for space, eleven different health centres and 
one referral hospital were included in the study. Concurrently different cadres and professions 
like registered nurses, nurse midwife technicians, clinical officers, medical assistants and patients 
participated in this study. Using different types of triangulation in this study helped the researcher 
gain a deeper understanding of the phenomenon and also to have a broader scope of the context 
in which patients with pre-eclampsia and eclampsia are managed [54]. It also helped the 
researcher to develop confidence in the data that were collected. Focus group discussions were 
used to confirm and validate data obtained from the individual interviews. 
3.2 Setting 
3.2.1 Blantyre 
 
The study was conducted in Blantyre District, the commercial capital city of Malawi in the 
southern region. Blantyre district has a population of 1,001,984. Out of this population, 661,256 
live in the city. Females contribute to 500, 984 of the population and women in the reproductive 
age group (15-49) contribute to 265,912 of the female population [55].  
Blantyre District does not have a district hospital; hence health centres refer patients directly to 
the tertiary hospital which in this case is Queen Elizabeth Central Hospital (QECH). This study 
was therefore conducted at QECH and in health centres that refer patients to QECH’s maternity 
unit Chatinkha. Chatinkha maternity unit was chosen because it is where obstetric complications 
including pre-eclampsia and eclampsia are managed and it is also situated within reach to the 
residential area for the researcher as such it proved convenient in terms of cost and accessibility 
to the facility.   
 
Chatinkha maternity unit has a total of 250 beds for both obstetrics and gynecological patients. It 
conducts approximately 7000 deliveries per year and 17% of these deliveries are complicated 
with pre-eclampsia and 4% develop eclampsia. The maternity unit sees over 2000 new 
gynecological patients in its outpatient clinic. Apart from clinical activities, Chatinkha acts as a 
teaching and training unit for students from its surrounding colleges including University of 
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Malawi College of Medicine and Kamuzu College of Nursing, Malawi College of Health 
Sciences, Trinity and St Joseph Colleges of Nursing.   
 
At Chatinkha maternity unit, the study was conducted in the labour ward and at the postnatal 
ward. Labour ward is the place where all patients referred with severe pre-eclampsia and 
eclampsia are admitted and managed. On average Chatinkha labour ward conducts more than 20 
deliveries per day. The postnatal ward, on the other hand is where the patients from labour ward 
or operating theatre are transferred when they have delivered their babies and are out of danger.  
Discharge from the hospital is also done from this ward. The two wards were basically chosen in 
order to get easy access to the health care providers, records and patients with pre-eclampsia and 
eclampsia. 
 
There are two postnatal wards at Chatinkha maternity unit with 50 beds each; however during the 
study period only one ward was operating due to some renovations that were going on. Routine 
activities in the ward include postnatal checkups before discharged, wound dressing, doctors’ 
rounds, monitoring of patients with complications like pre-eclampsia and eclampsia when they 
are out of danger, drug administration and post- operative care for caesarean section patients. 
Rooming in is only 12 hours for women with uncomplicated normal deliveries due to limited 
space. 
3.2.2 Health centres 
 
There are a total of 22 health centres that refer to Chatinkha Maternity Unit. The farthest health 
centre being located 75km away (Figure 3).  Regardless of the distance and the geographical 
locations, all these centres provide reproductive health services, besides other general health 
services. In this study 11purposively selected health centres were included.  
A typical health centre in Malawi has a total of 12 maternity beds; two  delivery beds, and 10 
post natal beds[ BDHO local report].The  postnatal beds are used for both rooming in for 
postnatal mothers and for antenatal mothers who are in latent phase of labour or are waiting for 
referral to the central hospital. Normally rooming in is 24 hours, unless there is a problem 
requiring further observations.  
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Staffing at the health centre includes nurse midwife technicians, enrolled nurse midwives, clinical 
officers and medical assistants. All these cadres except for medical assistants undergo a 3 year 
similar training program which prepares them to perform as skilled birth attendants [36]. 
 
The number of skilled health care providers in these health centres varies with location; ranging 
from as low as one health care provider to as many as 19 health care providers; with urban health 
centres having more staff than the rural. The catchment areas for the health centres also varies, 
from 9000 to 148000, with urban health centres having wider catchment areas than their rural 
counterparts [55].   
 
Services offered at these health centres include antenatal care, normal delivery and post natal 
care, family planning, under-five clinics, Voluntary counseling and testing for HIV, Ante- 
retroviral treatment clinics. On an average antenatal booking day urban health centres attend to 
over a 100 new clients, and conduct 5 deliveries per day. On the other hand, rural health centres 
attend to 20 new antenatal clients per booking day and conducts 3 deliveries per day on average. 
 
Semi-structured interviews and a focus group discussion were conducted with health care 
providers in 11 purposively selected health centres which had referred patients with pre-
eclampsia and eclampsia to Chatinkha maternity unit from 1
st
 September to 31
st
 December 2012. 
Purposive sampling implies deliberative selection of participants, sites, documents or visual 
materials that best help the researcher to understand the problem and answer the research 
question [52; 53]. In this study the sites were chosen basing on the interrelationship between the 
two facility levels and the condition under study. The health centres are an entry point of patients 
with pre-eclampsia and eclampsia to the formal health care delivery system; as such any 
management offered to these patients at this facility has an implication on patients’ outcome at 
the referral facility; which in this case is Chatinkha maternity Unit, of QECH 
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Figure 3: Map of Blantyre indicating health centres 
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3.2.3 Selection of health centres 
 
Selection of health centres was based on patients referred from health centres. With consent from 
the in-charge of Chatinkha labour ward in addition to consent by COMREC, the researcher 
checked admission registers on a daily basis for new patients referred from the surrounding 
health centres. The register contains patients’ information about name, age, from where they had 
been referred and the reason for referral. Only patients who had been referred due to pre-
eclampsia and eclampsia were included into the study. These patients were then approached for 
consent to participate in the study and to review their records.  Since the setting at Chatinkha 
labour ward is such that patients with pre-eclampsia and eclampsia are nursed in an intensive care 
unit within the ward; it was easy for the researcher to identify them. After obtaining a verbal and 
written consent from the patient, she was asked from where she was referred in order to confirm 
if she had been referred from another facility and about the care she received before referral. The 
health centre from where she had been referred was noted and purposely sampled as a 
participating centre. A day or two after an interview with an eligible patient, the researcher made 
a follow up visit to that respective health centre and if available interviewed the healthcare 
providers who took part in referring the patient, and those who usually take part in the 
management of pre-eclampsia and eclampsia even if they did not send this particular patient. 
Immediate follow up to the health centres was done to take advantage of their short lived 
experience in order to minimize recall bias owing to the fact that the conditions in question are 
considered rare. However, not all health centres that referred patients with pre-eclampsia and 
eclampsia during the study period were included in the study due to cost and time constraints 
since all activities were done by the researcher herself. 
3.3 Study population 
 
Two groups of people were targeted in this study. The first group was of healthcare providers 
working at a health centre that refers patients to Chatinkha maternity unit of QECH and who 
would have referred a patient with pre-eclampsia or eclampsia during the study period. This 
group included clinical officers, enrolled nurse midwives, nurse midwife technicians and medical 
assistants. These profession cadres have different pre-service training as well as qualifications as 
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follows: registered nurses have four years pre-service training and possess degrees, nurse 
midwives technicians and enrolled nurse midwives have three years pre-service training and have 
certificates; clinical officers have four years pre-service training and have diplomas and lastly 
medical assistants are clinicians with two years pre-service training and they also possess 
certificates. Use of different cadres with different pre-service training helped to have diverse 
degrees of the participants’ understand of the two conditions understudy. The second target 
within the same group was healthcare providers at Chatinkha maternity Unit who admitted a 
patient referred from these health centres. Healthcare providers at Chatinkha included registered 
nurse midwives, enrolled nurse midwives and nurse midwife technicians.  
The third target group was women who had been referred due to pre-eclampsia and eclampsia 
from a health centre. These were included because they helped to link the information obtained 
from health care providers from the two levels of care. 
Inclusion criteria 
 Skilled birth attendants from participating health centres. They included 
nurse/midwives, nurse midwife technicians, clinical officers and Medical Assistants 
only when it was learnt that they participate in maternity care 
 Nurse/midwives working from Chatinkha labour ward who had admitted a referred 
patient with pre-eclampsia and eclampsia from a health centre 
 Mothers who had been referred due to pre-eclampsia and eclampsia from the health 
centres  
Exclusion criteria 
  Patients of pre-eclampsia and eclampsia  who attended antenatal care at Chatinkha, 
because they were already under specialist care at Chatinkha 
 
 Student nurse midwives and student doctors were excluded because they were still 
learning and they were not allowed to deal independently with obstetric complications 
3.4. Sampling 
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Purposive sampling of nurse midwives, clinical officers and medical assistants in purposively 
selected health centres was done. At least one semi-structured interview was conducted with 
whichever cadres who had participated in the management of the patients in question, were 
available, and consented to the interview. This helped the researcher to reach all cadres that were 
involved in the management of complications of pregnancy at the first level of care; and it also 
helped her to get diverse perspectives, experiences and views from the different cadres at this 
level. Semi-structured interviews were also conducted with healthcare providers at Chatinkha 
maternity unit labour ward. These healthcare providers were included in the study because they 
were the ones who attended to the referred patients who had pre-eclampsia and eclampsia.  As 
such they were key to information on the patients’ conditions on arrival to the referral hospital. 
One focus group discussion (FGD) was conducted with the participating midwives from the 
different health centres to complement the data collected from the individual interviews. No FGD 
was conducted with clinical officers or medical assistants because there were basically no clinical 
officers in most of the health centres and where they were available, there was only one per 
health centre, so asking him to participate in a FGD would  have  disrupted the normal 
functioning of the health centre which is unethical. Moreover, being few in number, they would 
not form an adequate group for a focused discussion [52]. The type  of participants in this study 
were  chosen  in order to target the people that make and carry out decisions about patients’ care 
in the  health centres and this fact made them better and right informants. All the cadres at these 
health centres except for medical assistants are trained to proficiency in the skills needed to 
manage normal (uncomplicated) pregnancies, childbirth and the immediate postnatal period, and 
in the identification, management and referral of complications in women and newborns [36]. 
Medical assistants were included in this study where it was clearly indicated that they 
participated in management of maternity complications at the health centre including pre-
eclampsia and eclampsia. 
Semi-structured interviews were also conducted with patients who had been referred from the 
health centres with pre-eclampsia and eclampsia in order to link the information obtained from 
healthcare providers at the health centres, thereby increasing understanding of issues surrounding 
the conditions from different angles.  
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3.5 Data Collection 
 
Data collection started on 9
th
 of September through 31
st
 December, 2012. Data were collected 
through review of patients’ records, non-participant observation, one-on-one semi-structured 
interview and a focus group discussion using a structured interview guide that was developed 
based on the research questions. The interview guide had basically open-ended questions. 
3.5.1 Review of case notes 
 
The researcher did a review of all case notes of patients who were admitted with pre-eclampsia 
and eclampsia during the study period to determine the burden of pre-eclampsia and eclampsia at 
Chatinkha maternity unit and to determine how many were referral from health centres. This 
aided the researcher to identify health centres that were included in the study. It also helped to 
identify patients and health care providers at Chatinkha maternity unit to be included in the study.  
3.5. 2 semi-structured individual interviews with patients 
 
With the aid of an interview guide (Appendix II), the researcher conducted six one-one semi-
structured interviews with four patients and two guardians of patients referred from the health 
centres with severe pre-eclampsia and eclampsia in the first month of study. The guardians were 
involved because the condition of their patient could not allow her to talk or remember what 
really happened at the health centre, secondary to convulsions. The interviews were done to link 
information obtained from health care providers at the health centres, and at Chatinkha Maternity 
Unit, thereby increasing the general understanding of the issues surrounding these conditions. 
Only a few patients were interviewed since the main aim of including them was to identify health 
centres to be included in the study and not to assess quality of care from their point of view. 
Patients were asked questions pertaining to their ability to recognize pre-eclampsia and 
eclampsia, like what symptoms made them seek medical help, how they were received and 
treated at health centre and how they were referred to Chatinkha maternity unit. These interviews 
lasted 20 minutes on average. In addition to the six interviews, with the consent of the labour 
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ward in-charge two records of dead women were also reviewed as a pre-requisite to selection of 
health centres to be included in the study. All interviews were conducted in local language. 
 
3.5.3 Semi-structured interviews with health care providers 
 
Semi-structured interviews were carried out with 8 purposively selected healthcare providers at 
Chatinkha maternity Unit and 21 healthcare providers participating health centres using different 
interview guides which were developed prior to data collection. 
3.5.3.1 Semi-structured individual interviews at health centres 
 
Semi-structured interviews were carried out with 21 purposively selected health care providers in 
purposively selected health centres after a thorough explanation of the purpose of the study and 
after obtaining a written consent form. Semi-structured interviews were conducted with a fairly 
open framework which allow for focused, conversational, two-way communication. The majority 
of questions were created during the interview, allowing both the researcher and the interviewee 
the flexibility to probe for details or discuss issues [52]. These interviews were conducted using 
an interview guide which was developed prior to onset of data collection (Appendix III). The 
interview guide changed depending on new issues arising from preceding interviews with health 
care providers. The interviews were conducted by the researcher herself and they lasted between 
35 to 50 minutes, depending on the responses of the participant. All the interviews were 
conducted at the participant’s work place in a private room which was identified by the 
participant her or himself. Conducting interviews at their own place was less intimidating for the 
participants due to the familiarity of their environment. It also helped to emphasize the fact that 
they were the experts and in control of the interviews at that moment in time. The interviews 
were conducted outside working hours which included at lunch time or after work to avoid 
disrupting their work routines. This helped to create a relaxed environment that would otherwise 
be lacking if one had to rush to attend to patients.  
3.5.3.2 Semi-structured individual interviews at QECH (referral facility) 
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With the aid of an interview guide the researcher conducted semi-structured interviews  with 
nurse midwives at Chatinkha Maternity Unit of QECH who had admitted a patient with pre-
eclampsia and eclampsia during the study period. Participants were identified through patients’ 
records, and they were invited to participate in the study after a thorough explanation of the 
purpose of the study. The interviews were conducted in a private nurses’ office which was 
offered by the in-charge. These interviews lasted 20 minutes on average. A different interview 
guide was used at this level of care. Among other things health care providers were asked to 
explain the condition of the patient on arrival to Chatinkha and why they thought the patient 
arrived in that state (Appendix IV). 
3.5.4 Focus group discussion 
 
One focus group discussion was conducted with 6 midwives from the purposively selected health 
centres. An invitation to participate in the focus group discussion was made at the end of the 
individual interviews. Nine health care providers were invited to participate. Two refused to 
participate because of distance and difficulties with transportation; one health care provider could 
not make it on the date of interview.  However, literature on FGD indicates that participant size 
of between 6 and 10 is adequate with the ideal size being between 5 and 10 participants [58]. 
Therefore, the size in the FG for this study was appropriate and acceptable. A focus group 
discussion is a qualitative method that helps to investigate a range of opinions or practices or 
normative aspect of behaviour [53]. In this study, a focus group discussion helped to investigate 
the normal practices and challenges among the different health centres concerning the 
management of patients with pre-eclampsia and eclampsia; and it also enriched and 
complemented the individual interviews. The focus group discuss was conducted at the college of 
medicine obstetrics teaching annex which was considered to be a neutral place for all the 
participants in this focus group. Choice of a neutral place in this case helped to minimize a 
feeling of being a host to colleagues which could otherwise have arisen if one health centre was 
chosen for the discussion, which could be psychologically challenging for the hosting participant 
[52; 53].  
 
The focus group discussion was facilitated by the researcher herself and notes were taken by a 
research assistant who was previously trained for that purpose. A guide that was used for the 
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focus group discussion was developed from issues that arose from the different individual 
interviews (Appendix V). The FGD took a total of two hours. 
Both the individual interviews and focus group discussions were conducted in the local language 
(Chichewa) (Appendix VI-VIII) which allowed for free and full   expressions of respondents’ 
experiences.  Open-ended questions were asked on health care providers’ experiences with 
diagnosis, management, challenges and opinions for improvement of the management of patients 
with pre-eclampsia and eclampsia. 
 All the individual interviews and the focus group discussions were digital audio tape recorded to    
minimise time and to ensure completeness of the data collected.  However, this was done with 
participants’ consent.  
3.5.5 Inventory and observation 
 
An inventory of resource availability was performed in the selected health centres using a 
focused checklist. This was done to triangulate and complement the individual interviews and 
focus group discussion findings.  The checklist included a blood pressure measuring machine, 
stethoscope, intravenous fluids, magnesium sulphate, hydralazine, protein dipsticks, and Oxygen 
syrinders, bladder catheters and urine collection bags, thermometers (Table 4). All these supplies 
are essential in the management of pre-eclampsia and eclampsia.   
The researcher also did non-participant observation in the purposively selected health centres to 
determine how identification of patients with pre-eclampsia was done by health care providers in 
these health centres; that is whether mothers are educated on danger signs of preeclampsia and 
whether blood pressure check was done on antenatal mothers or not. Covert non-participant 
observation was done in this study as opposed to participant observation, to minimize researcher 
influence on participant behaviour and to minimize undue inducement that could arise from 
actively getting involved in participants’ life world [53]. Since there were only two things that the 
researcher intended to observe in relation to the management of pre-eclampsia, she did not 
develop any checklist; observations were just tallied.  
3.5.6 Pre-testing of data collection tool 
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Three pilot individual interviews were conducted with midwives at one of the health centres not 
included in the study. The pre-testing helped to test for the comprehensibility, acceptability  and  
interpretation of certain words by respondents, the length of time required per interview, and 
interview conditions the researcher could have potentially faced , which could have disrupted the 
recording or flow of the interview [52]. Following the pre-testing some questions were rephrased 
to make them more comprehensible for the participants. Evaluation of the interview guide was 
on-going depending on new issues emerging from preceding interviews in order to explore such 
issues in the subsequent interviews. Due to financial limitations, no pre-testing was done for the  
interview guide for health care providers at the referral facility, since it required travelling to a 
district hospital. As such some changes were on going based on proceeding interviews. 
 
Summary of data collection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient’s Consent 
 
Review of patients records 
 
Interview with patient 
 
Interview with HCP QECH 
 Interview with HCP health centre 
 
Inventory and observation 
i 
Checklist pre-referral care 
FGD 
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3.5.7 Management and Analysis of data 
 
 Data analysis process 
The initial data analysis started simultaneously with data collection in the field. Digital audio 
recorded individual interviews as well as the focus group discussion were uploaded on a 
password secured computer on the same day of  the interview to prepare them ready for 
transcription and protect participants’ confidentiality. The researcher transcribed them verbatim 
in local language immediately following the interview. This helped the researcher to continuously 
evaluate the data for new emerging themes which were then explored in the subsequent 
interviews and observations. The transcribed transcripts were translated into English by the 
researcher and a fourth year medical student to control for researcher biased translation.  
 Focused data analysis 
A systematic and focused data analysis was done following the completion of data collection 
period. An inductive general approach of analysis as described by Thomas, 2003 was used. In 
general, the inductive approach data analysis is determined by both research objectives 
(deductive) and multiple readings and interpretations of the raw data [56]. 
The first step in this process was organization of the raw data. Transcripts were grouped 
according to different sources, different sites, different levels of facility and different data 
collection methods. The entire data set was read through, redundant sentences were removed, 
typo errors and spelling mistakes were corrected in order to clean up the data. This was followed 
by further reading and rereading of the text to become familiarized with the data and to gain an 
understanding of common themes that were emerging from the text. The meaningful segments 
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from the text were then marked with different font colours to symbolize different themes and a 
label was assigned at the end of the text to signify that particular text. This process is called open 
coding [56].  This process was continued until all transcripts from the two different levels were 
completed. The initial labels in the text were written down separately to keep record of the 
original code list. Notes were made simultaneously to reflect what was coming up in relation to 
the research questions and objectives. Some of the transcripts were given to two other final year 
students; one master degree student and one PHD student to read and to independently come up 
with code lists of their own. Similarities and differences were noted on the two code lists and 
were discussed with the other student researchers. The merged list was then systematically 
applied to the whole data set; repeated codes were eliminated or merged. New codes were added 
to the list simultaneously. The subthemes were then merged and grouped into main categories. 
The codes were then grouped into sub-themes and main categories according to their 
relationships (Appendix.  
 
Descriptive data analysis for patient characteristics, health care provider characteristics, pre-
referral care checklist and resource availability checklist was performed using SPSS version 20. 
 3.6 Trustworthiness 
 
Trustworthiness is the extent to which the findings are an authentic reflection of the personal or 
lived experiences of the phenomenon under investigation [52]. It is a way of ensuring and 
increasing confidence that the study findings represent the meaning by the study participants 
[52]. Trustworthiness of a study is important to evaluating its worth. There are four criteria that 
are used to evaluate trustworthiness of a qualitative study. These include credibility, 
dependability, confirmability and transferability [52]. 
 
 Credibility 
In qualitative research credibility means the findings are believable and trustworthy from the 
perspective of a participant or subject in the research itself [52]. It is a way of demonstrating that 
the research was designed to maximize the accuracy of identifying and describing whatever 
phenomenon is being studied. In this study three methods were used to enhance credibility. These 
include triangulation in data collection, and peer debriefing. The current study sought to explore 
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and understand the perspectives of first level health care providers on the management of pre-
eclampsia and eclampsia before referring for specialist care at the tertiary level. Due to its 
exploratory nature as well as the desire to create an environment for free expression of views by 
participants, a qualitative method was deemed a good fit for the purpose of the study than 
quantitative methods which commonly deal with quantifications [53]. 
Data collection was triangulated at three levels; methods, place and person. Triangulation of 
methods included individual interviews, focus group discussion and observation. Acknowledging 
that these methods individually have their own limitations, triangulation in this study helped to 
exploit individual method benefits and to compensate for the individual limitations. 
Triangulations also helped to link data and determine commonalities in issues that emerged from 
all methods as well as both levels of care. No major differences in information obtained from 
individual interviews from different places and from FGD, and the observations corroborated 
information from individual interviews and focus group discussion. Both individual and focus 
group discussion were done by the researcher who is conversant with the local language and 
culture of the study setting. The use of local language helped to probe and elicits deep 
clarifications from the participants, which would otherwise be difficult to obtain in a second 
language like English. Translation of the transcripts for this study was done by two independent 
people; the researcher and fourth year medical student. The transcripts were compared for any 
differences. Apart from differences in the vocabulary, the same themes emerged from the two 
sets of the transcripts. This was done to control for potential researcher bias. Determination of 
themes was also done by the researcher and another student researcher of the master of 
international community health to compare and merge the main issues in order to come as close 
as possible to interpretations of participants’ views and experiences. Recruitment of health care 
providers at the first level facility of care was done immediately following their referring a 
patient to the referral facility, and this helped to reduce potential recall bias. Additionally, to 
increase honesty in this study, participants were recruited on voluntary basis and freedom to 
withdraw at any time during the study was emphasized. Participants were not obliged to give 
information they felt uncomfortable with, and this ensured free expression of views by the 
participants.  
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Debriefing sessions with the supervisor and co-supervisor in this study helped to widen the 
understanding of the issues emerging from the data and to come as close as possible to the 
interpretations of the participants’ perspectives.  
 Dependability 
Dependability means the ability to be trusted.  It means worthiness as a recipient of another’s 
trust or confidence [57]. Dependability in qualitative research involves accounting for all the 
changing conditions in whatever is being studied as well as any changes in the design of the study 
that were needed to gain a better understanding of the context [52]. The methods that were used 
to enhance credibility in this study as described above also helped to enhance and strengthen 
dependability for this study.  
 Confirmability 
 
Confirmability refers to the objectivity or neutrality of the data so that two or more independent 
people can reach an agreement about the data’s relevance or meaning [52]. To enhance 
Confirmability in this study, transcripts were made available to fellow student researchers as well 
as to the co-supervisor. The patterns and themes were also discussed with a fellow student 
researcher and the main and co-supervisor. The data tools are attached as appendices to this thesis 
and transcripts are available upon request for interested researchers. 
 
 Transferability 
 
Transferability refers to the generalizability of the data, that is, the extent to which the findings 
from the data can be transferred to other settings or groups [52]. The topic and the context in 
which this study was conducted were described in great detail. The data tools are attached as 
appendices to this thesis and transcripts are available upon request for interested researchers who 
may want to repeat as closely as possible the procedures which were carried out in this study.  
 
 Reflexivity 
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Reflexivity in qualitative research means that researchers become aware of how their biases, 
values and personal background such as gender, history, culture, and socio-economic status, 
influence how the study is designed, implemented, data collected, analyzed, and interpreted, and 
findings reported [52]. Self -awareness in this study was an on-going process from identification 
of the research area, to writing up of the research findings. I am a nurse midwife by profession 
and have worked at a teaching referral hospital (QECH) as a bedside nurse/midwife, supervisor 
and as a clinical teacher. I was part of a maternal audit team at this hospital and through the audit 
meetings I gained more knowledge of some of the substandard care that goes on at different 
facility levels of care. In 2000 to 2002, I was privileged to participate in recruiting patients with 
pre-eclampsia and eclampsia for the Magpie trial in which the benefits of magnesium sulfate 
treatment for women with pre-eclampsia and eclampsia and their babies was assessed . It was 
through all these experiences that I became interested in the condition under study. My 
experience coupled with an in-depth literature review therefore dictated how the study was 
designed and how questions were framed. I have never worked at the health centre level and was 
not very familiar with the real world at these centres which worked to my advantage because it 
made me more interested in the participants’ views and it made them feel comfortable to share 
their experiences.  
 
At the first health centre where I tested the data collection tool, I was perceived in two different 
ways. Before I introduced myself I was viewed as any other client seeking health services and I 
was given the same reception like any other client. This assured me that I dressed and looked 
simple enough as a student. This was advantageous to me because my presence and presentation 
did not cause undue influence on their part as participants. However, the story changed when I 
went to the referral hospital for interviews with care providers. When I introduced myself as an 
international student to the in-charge, I aroused her interest in how I found myself to be an 
international student. I knew this would be a big problem with every potential registered nurse I 
might encounter to interview because they have the qualifications to apply for the master’s 
degree program. A similar encounter was with a registered nurse midwife at the first health centre 
where I conducted interviews. When I introduced myself to her as a student of master degree in 
international health, she in turn started enquiring about my master program and how she could 
apply for it before she granted me the permission to interview her subordinates. This could be 
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attributed to the fact that there are limited opportunities for upgrading in Malawi and many nurses 
are looking for such upgrading opportunities. Nevertheless it made me feel uncomfortable 
because it might have introduced undue inducement to participate in the study. Fortunately, most 
of the participants in this study were not registered nurses, and the registered nurses who 
participated were not as inquisitive as the two in-charge nurses. This helped me to freely 
interview the participants without fear of undue inducement. 
 
Being born and raised in Malawi, I was opportuned to conduct the interviews in the local 
language (Chichewa) and to govern myself according to culturally acceptable standards. Ice 
breaking questions were used in all the interviews in order to establish rapport and to create a free 
and conducive atmosphere for the participants. Furthermore, participants were reassured that 
there was no right or wrong answers and that the discussions were confidential. Their freedom to 
withdraw from the study was also emphasized. The participants were given freedom to ask for 
clarifications on any of the questions during the interviews. Communicating in the local language 
helped the participants to be open with me and express themselves candidly. I used a journal to 
write and reflect on how the interviews were conducted and improvements were made on 
possible areas that might have affected what was shared during that particular interview.  
3.7 Dissemination 
 
The report for this study project will be finalized and handed over to the University Of Oslo 
Department Of Community Health as a master thesis. The findings will also be disseminated 
through conferences at the Malawi College of Medicine and Kamuzu College of Nursing. Copies 
of the report will be sent to the Blantyre District Health Office and to QECH in Malawi to make 
them aware of the situation at hand. Dissemination will also be done through workshops, briefing 
meetings at research sites and personal communication. Publication will be sought with 
international reproductive health journals and local journals. 
3.8 Ethical consideration 
 
The declaration of Helsinki states that cconsiderations related to the interests and well-being of 
the human subjects should take precedence over the interests of science and society [58]. It is a 
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requirement therefore, that every researcher  should protect his/her participants; in order to 
develop trust with them; promote the integrity of research; guard against misconduct and 
impropriety that might reflect on his/her organization or institution [58]. This study was approved 
by the Regional Research Ethics Committee in Oslo, Norway (Appendix X), and by the College 
of Medicine Research Ethics Committee (COMREC) of Malawi (Appendix XI). Permission to 
collect data at the study sites was obtained from the Blantyre District Health Office which is 
responsible for all the health centres in Blantyre District as well as from the in-charge at the 
health centres (Appendix XII). Permission to do individual interviews with midwives and with 
postnatal mothers with pre-eclampsia and eclampsia at Chatinkha Maternity Unit of QECH was 
obtained from the hospital director of QECH as well as from the Head of Department and the 
Unit matron. (Appendix XIII).  
3.8.1 Informed consent, confidentiality and anonymity 
 
Both oral and written individual informed consents were obtained from the participants after a 
thorough explanation of the study aims, procedure, expected benefits, risks and expected 
responsibility of the participants which was done in local language. The consent forms which 
were written both in local and English language were given to them to read on top of the oral 
explanation (Appendix XIV-XVII). Participants were informed of their freedom to quit at any 
time during the interviews if they felt so.  
 
Anonymity and confidentiality of participants were ensured through depersonalization of data 
during data collection, limiting who had access to the data and stored in a password secured 
computer. During the interviews participants were asked not to mention their names. All consent 
forms with their signatures were kept separately from their transcripts so that no connection could 
be made in anyway. Participants were informed and assured that digital audio recorded 
information was not for broadcast and no quotes would bear their names. During the FGD, 
participants were informed that whatever was discussed in the group needed to remain 
confidential among themselves. 
 
The interviews with health care providers were conducted in a private room of their choice and 
this helped to facilitate open and free discussion and ensured participant privacy. All questions 
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asked by the participants concerning the study were clarified before they consented to participate 
in the study. Contact information of the researcher and the COMREC was given to them in case 
of further questions after the interviews.  
 
The use of tape recorders in interviews and the FGD was approved by all participants after a 
thorough explanation of the purpose for its use was given. The participants were informed that 
the tape recording was required to minimize time for the interview and to accurately capture all 
their views. Participants were informed that they were free to request the researcher to turn off 
the recorder at any time if they felt uncomfortable with its use. Even though participant approved 
the use of their descriptions to explain findings, no names or addresses were used in the 
presentation of the findings to ensure complete anonymity.  
3.8.2 Benefits, Costs and Risks 
 
The benefits of this study were at the individual, societal, and policy level. Individually, the study 
helped healthcare providers to reflect upon their daily practice and to identify their own gaps and 
to suggest ways of improvement in the management of pre-eclampsia and eclampsia. The society 
potentially benefits because with improved care morbidity and mortality will be reduced. It is 
envisioned that the finding from this study will inform authorities on areas that need 
improvement in the management of patients with pre-eclampsia and eclampsia at the first level of 
care; as such it is hoped that strategies will be put in place for improvement. 
Participants were made aware of and given travel- costs reimbursements for FGD at the end of 
the discussion to ensure that there was no unintended financial inducement. Due to the fact that 
interviews were conducted mostly during lunch hour, lunch was provided at the end of the 
interview as an incentive; however this was not communicated to the participants prior to the 
interview to avoid undue inducement. 
In summary several methods were used to collect data for this study as has been deeply described 
in this chapter.  The next chapter presents findings from this data collection. 
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3.8.3 Methodological discussion and limitations of the study 
This section discusses the challenges faced while utilizing the selected data collection methods. 
Specifically, the interviews, observations and public discourse analysis are discussed. It also 
includes a discussion about the limitations of the study in general. 
3.8.3.1 Strength 
3.8.3.2 Design 
The use of qualitative design in this study was proper for the purpose of the study. The study 
sought to explore health care providers’ perspectives. This design allowed for free expressions 
from health care providers. The flexibility of the data collection methods also allowed for 
exploration of issues emerging from individual interviews. The use of triangulation helped to 
facilitate a deeper understanding of the context in which management of pre-eclampsia and 
eclampsia is done [52]. The use of local language both in individual and focus group discussion 
by the researcher helped free exploration and expression of views by researcher and participants 
respectively, without being limited by difficulties that exist with use of second language. 
3.8.3.3 Choice of site 
The study is one of a kind that focus on the views and experiences of health care providers at the 
first level in the district This will help to increase recognition of this group of people in the health 
care delivery system. The use of both urban centres and rural centres helped to have a general 
picture of the burden of pre-eclampsia and eclampsia as well as to compare the context in which 
these conditions are managed. As such, due to similarities in the context, the focus group 
consisted of both rural and urban participants. 
3.8.3.4 Procedure for sampling of sites 
Selection of health centres depended on patients referred from those health centres. If a patient 
was referred from a particular health centre, that health centre was immediately followed up to 
invite the health care providers to participate in the study. This reduced recall bias because the 
health care providers based their responses on the recently referred patient. Additionally, health 
care providers did not know that the researcher knew about the patient they had referred to the 
referral facility to avoid giving them a feeling of being blamed for any substandard care that they 
might have provided. Interviews were conducted at the health centres and at their convenient time 
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to avoid rushing the interviews which could limit views of participants and the places for the 
interviews were chosen by the participants themselves. 
3.8.4. Limitations 
There were several limitations which were encountered in the course of this study. These 
included design, recruitment of participants, data collection, and cost.   
3.8.4.1 Design 
The study design and methods that determined the sample sizes and sampling procedures of the 
health workers in Blantyre made the results generalizable only to participants who share similar 
characteristics and settings. In short, the findings of this study are tentative as they are inductively 
developed, prone to subjectivity and subject to modification through subsequent research 
findings. Similarly, although they may have a wider applicability in the field of pregnancy 
management, they can only be generalized to the sample under study.  
 
3.8.4.2 Recruitment of participants 
Interviews with health care providers at the referral facility were originally planned to be done as 
soon as possible after identification of the patient admitted from the health centres. However, it 
was discovered that not all health care providers working in the labour ward at the referral facility 
were permanent staff; some were on locum(worked on part-time to cover for shortage). As such it 
was difficult to meet some of the health care providers in time due to their movements between 
the two work places. In some cases, the researcher had to locate and follow these health care 
providers to their origin work places to invite them for an interview in order to minimize the time 
elapse. This might have introduced some recall bias in the study because the participants had to 
remember when they last did locum and which of the cases they admitted had pre-eclampsia or 
eclampsia. In some cases, it required to retrieve a file for them to remember.   
3.8.4.3 Data collection 
Initially, it was planned to conduct repeat interviews but this was not possible due to cost. The 
budget had actually doubled due to devaluation of the Malawi Kwacha, which was not 
anticipated during the planning and budgeting phase of the study. Eight participants were invited 
for FGD, but one could not attend because it was rainy season and the roads were impassable, 
and the other one had an emergency at home, so only six people participated. Males were not 
well represented in the FGD; there was only one male health care provider, which might have 
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made him feel uncomfortable to freely express himself. The others two male participants who 
were invited are the ones who could not make it. Due to non-inclusion of supervisors in this 
study, it was difficult to confirm some of the information from health care providers at the first 
level facility. 
3.8.4.4 Type of participants 
Originally, it was hoped to fairly represent all cadres at the first level facility of care. 
Unfortunately, other cadres were not available, such as clinical officers. For those health centres 
that had clinical officers, the clinical officers could not be found. They had either gone for a 
workshop, on leave, or had just come for locum at the health centre. As a result only one out of 
five clinical officers participated which is not representative enough. Furthermore, most medical 
assistants who were commonly found at the health centres were not involved in management of 
maternity cases and were not oriented to management of maternity cases in college. However, 
those included in this study stated that their training at a mission college oriented them to 
obstetrics and they participated in the care of these women at the health centre.  In spite of this 
inclusion, the findings from this study are not transferrable to this cadre because of the 
differences in their training.  
Only four patients and two guardians were interviewed in this study. The number was very small 
and their views may not be generalized to other patients. Use of guardians on the other hand 
might contribute to biased information. For example, they may not be in a position to know what 
patients learned at antenatal clinic.  
In summary several methods were used to collect data for this study. The processes of data 
collection as well as the limitations encountered in data collection have been deeply described in 
this chapter.  The next chapter presents findings from this data collection. 
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CHAPTER FOUR 
FINDINGS 
4.0 Introduction 
As discussed in the previous chapter on research methods, data for this study were collected 
through record reviews, non-participant observation, checklist, semi-structured interviews and 
focus group discussions (FGD). The main objective of this study was to explore first level health 
care providers’ perspectives on the management of pre-eclampsia and eclampsia. Findings in this 
paper have been presented using descriptions which have been supported by quotes from the 
interviews and focus group discussions. Quotations have been used to explain or illustrate to 
deepen understanding, to give participants a voice, and to enhance readability [52]. 
The section begins with a brief summary of the burden of pre-eclampsia and eclampsia at 
Chatinkha Maternity Unit, QECH, as observed during the study period. This is followed by 
presentation of the demographic information of the whole participants’ sample. Finally, a 
summary of the main findings of the study is presented in the following sections: Understanding 
of pre-eclampsia and eclampsia; management of pre-eclampsia and eclampsia, perceived benefits 
of pre-referral care, challenges in the management of patients with pre-eclampsia and eclampsia 
and suggestions for improvement. In this chapter, results from the analysis of the individual 
interviews and FGD data are presented. The first part presents findings from first level health 
care providers, followed by findings from interviews with health care providers and patients at 
the referral facility.  
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4.1 Disease burden at Chatinkha, QECH 
During the 4 months study period there were 306 patients who were admitted at Chatinkha 
Maternity Unit of QECH, with hypertensive disorders of pregnancy, of which 166 and 26 had 
confirmed pre-eclampsia and eclampsia, respectively (Table 1). There were a total of 3810 
deliveries during the study period, giving an average of 31 deliveries per day. The prevalence of 
all hypertensive disorders in pregnancy was 8%, and 5% for pre-eclampsia and eclampsia of the 
total deliveries. Pre-eclampsia and eclampsia accounted for 62.7% of the 306 cases of 
hypertensive disorders. Case fatality rate for eclampsia was 7.6%. Table 1 presents general 
characteristics of all patients with hypertensive disorders during the study period.  
 
Table 1: General characteristics of the patients with hypertensive disorders admitted at Chatinkha 
QECH (n=306) 
Variable Frequency Percentage (of 100%) 
Referral   
Referred 182 60.9 
Non-referred 117 39.1 
Missing 7 2.3 
Diagnosis   
Pre-eclampsia 166 54.2 
Eclampsia 26 8.5 
Hypertension 29 9.5 
Unconfirmed 79 25.8 
Missing 6 2 
Age group (years)   
<20 80 26.1 
21-30 163 53.3 
31 above 63 20.6 
   
Parity group   
0-4 278 90.8 
5 above 26 8.5 
Missing 2 .7 
Antenatal care   
Attended 298 97.4 
Not attended 2 .7 
Missing 6 2 
Mode of delivery   
Vaginal 216 70.6 
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4.2 Demographic information 
The demographic information presented here is for all the participants that took part in the study. 
The individual interviews’ sample consisted of health care providers drawn from Chatinkha 
maternity unit of QECH, and 11 health centres which referred patients with pre-eclampsia and 
eclampsia to Chatinkha maternity unit, and also mothers who were admitted with pre-eclampsia 
and eclampsia at Chatinkha between 1
st
 September and 31
st
 December, 2012. A total of 29 health 
care providers of different cadres were interviewed at the two different facility levels; 8 at 
Chatinkha and 21 from the different health centres. The cadres included registered nurse 
midwives, nurse midwife technician, enrolled nurse midwives, physician assistants (clinical 
officers) and medical assistants. Seven patients were invited to participate in the study of which 
one declined to participation. In addition to the 6 patients interviewed, two records of deaths were 
reviewed also as a pre-requisite for selection of health centres to be included in the study. 
Tables 2 and 3 show the demographic information of participants drawn from health care 
providers’ and patients respectively. As can be seen, there is diversity mainly in age, gender and 
mean work experience. 
 
 
 
 
 
Caesarean Section 89 29.1 
“ Undelivered” 1 .3 
Baby outcome   
Alive 251 82.0 
Died 42 13.7 
Missing 13 4.2 
Mother outcome   
Alive 304 99.3 
Died from eclampsia 2 7.6(case fatality) 
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Table 2: participant characteristics (health 
care providers (n=28) 
Age groups No. of participants 
Range 22 to 68 years  
20-24 2 
25-29 9 
30-34 4 
35 above 13 
 28 
Marital status  
Single 2 
Married 22 
Widow 4 
Gender  
Female 24 
Male 4 
Work experiences in 
years 
 
1  to 10 19 
11 to 20 4 
21 above 5 
Profession  
Registered nurse 
midwives 
3 
Enrolled nurse midwives 7 
Nurse midwife 
technician 
15 
Clinical officers 1 
Medical assistants 2 
Religion  
All Christians  
 
 
 
 
 
 
 
Table 3: Women participant characteristics 
(n=8) 
Age range 17 to 34  
Age groups No. of participants 
15-19 4 
20-24 2 
25-29 1 
30-34 1 
Marital status  
Married 7 
Widow 1 
Mode of delivery  
SVD 1 
Caesarean section 6 
Undelivered 1 
Outcome of mother  
Alive 6 
Dead 2 
Outcome of baby  
Alive 5 
Dead 3 
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4.2.1 Interviews with health care providers at the first level facility  
The section presents the main findings of the study from the 11 first level health facilities 
included in the study. The findings are presented under the following sections: understanding of 
pre-eclampsia and eclampsia; management of pre-eclampsia and eclampsia, perceived benefits of 
pre-referral care, challenges in the management of patients with pre-eclampsia and eclampsia and 
suggestions for improvement. 
4.2.2 Health care providers’ understanding of pre-eclampsia and eclampsia 
The first objective aimed at exploring first level health care providers’ understanding of the 
conditions of pre-eclampsia and eclampsia. This was determined through exploring their ability 
to describe the two conditions as well as their ability to detect and respond to the detected 
conditions. The results showed that generally there was good understanding of the two conditions 
among all cadres of first level health care providers who participated in the study. All the 21 
participants were able to come up with two main defining characteristics of the two conditions 
such as pregnancy and elevated blood pressure. Some participants (n=9) were even able to 
mention presence of protein in urine as a confirmatory test. They were able to differentiate the 
two conditions by stating the presence of convulsions in eclampsia. Except for a few participants 
(n=3), there was no mention of at what gestation pre-eclampsia presumably appears. When asked 
what condition pre-eclampsia is, the following participants described it like this, 
“Preeclampsia is when blood pressure is high in pregnant woman, not that person who has 
started fits, no. But Blood pressure is going up and has signs that the blood pressure is going up 
such as swelling of legs with high blood pressure above 140 over 90. On the other hand, 
eclampsia is when the blood pressure is high but she has started fits in pregnancy due to high 
blood pressure”. Nurse midwife technician  HC 8 
“Preeclampsia are signs that a woman shows like high BP (blood pressure) compared to what it 
is supposed to be in a person’s body who is pregnant, but she has other signs but is not fitting. 
Eclampsia means that she has convulsions and she also has a raised blood pressure and she is 
pregnant”. Medical assistant HC 1 
Almost all health care providers in this study were able to state how, when, and where pregnant 
women with pre-eclampsia are identified. The commonly mentioned place for detection of pre-
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eclampsia was antenatal clinic when women come for their antenatal visits. Apart from the 
antenatal clinic, they also mentioned the labour and postnatal wards. Some participants stated that 
some women ignorantly reported at outpatient department (OPD) with complaints of swollen 
legs, palpitations and shortness of breath, but were eventually referred to the labour ward with 
suspected pre-eclampsia. However, most participants expressed concern that in most cases they 
did not have essential tools to assist them to detect the conditions, and as such they just based 
their diagnosis on presenting signs and symptoms of the woman. The commonly mentioned tools 
lacking were blood pressure measuring apparatus (machine) and urine protein dipsticks (see 
Section4.2.5). When asked where patients with pre-eclampsia are detected, these health care 
providers stated: 
“At the OPD they are also found. Because sometimes we see that they are sent to us if they go to 
the OPD because of swollen legs, they may think that let me go to OPD and have a prescription, 
but when they get there; every pregnant woman is handled here at the maternity, which is why at 
the OPD they refer her here.  So I can say that some come from OPD, some from antenatal, and 
sometimes at postnatal, and sometimes even quite a number we identify them in labor ward when 
they come for delivery”. 
Nurse midwife technician HC 6 
 
4.2.3Management of pre-eclampsia and eclampsia 
4.2.3.1 Management of pre-eclampsia 
The second objective was to explore how patients with pre-eclampsia and eclampsia are managed 
at first level facilities before they are referred to the tertiary level facility for further management. 
With the exception of two private health centres, there were great similarities in the way patients 
were managed in most health centres. Reports from both individual interviews and the FGD 
revealed that management of pre-eclampsia at this level was based on severity of the condition. 
They stated that patients with mild pre-eclampsia were advised to have bed rest, low salt diet, 
their feet elevated if they have edema, and have regular blood pressure checks on weekly or 2 
weekly basis. In situations where a patient was coming from a very long distance (e.g. 10km), it 
was reported that the patient was admitted for two to three days for bed rest and for observation. 
These patients were referred to a hospital if condition worsened or did not improve. Nevertheless 
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this is without confirmation of diagnosis and without blood pressure machine in some cases. 
When asked how they dealt with women who came with pre-eclampsia at the health centre, they 
responded: 
“Pre-eclampsia is in two levels. There is mild BP of 140/80 or 140/90. These ones they say we 
can just advise them on rest and low salt diet and give them time to observe. We tell them to come 
on the following week for a BP check. Sometimes when they come back the BP is normalized. But 
if the BP is still high or is still rising, then we send her to Queens for further management”. 
Registered nurse midwife HC 9 
“It depends the way a patient has presented, if the symptoms are severe we refer right away to 
central hospital, but if we see that the symptoms are mild we advise the patient like  low salt diet, 
bed rest and the like, but if she presents with risk factors then we refer immediately to go for 
proteinuria check and the like” FGD 
 
As opposed to the government health centres, at the private health centres, health care providers 
reported that when the patients were identified at the antenatal clinic, they were referred to the 
assistant physician (clinical officer) who prescribed antihypertensive drugs, and the patient was 
still advised for a hospital delivery.  
“When she went to [  ] she was given atenolol and  HCT of which  here we say that, drugs like  
atenolol we give to someone not pregnant, but has high BP. And again HCT we give to someone 
who has already  delivered, so on our part we felt that, that was a problem” 
Nurse midwife technician 3-referral facility  
“When you find a person with high BP antenatally you also send her to the clinician to see and 
prescribe drugs for her” Nurse midwife technician  HC 8 
 
On the other hand, all participants reported that all patients with severe pre-eclampsia are 
immediately referred to the hospital for further management. When asked what pre-referral 
treatment was offered to the patients, most participants reported that there was no pre-referral 
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treatment given. The majority of the participants were uncertain whether magnesium sulphate 
was recommended as treatment for severe pre-eclampsia, and most of them reported that they had 
never given it to pre-eclamptic patients before. However, some participants acknowledged that 
the guidelines on the management of pre-eclampsia and eclampsia in the health centres 
recommended using magnesium sulphate, but they too had never used it for such patients. Some 
FGD participants attributed non-use of magnesium sulphate in pre-eclamptic patients to the fact 
that they had no urine protein dipsticks to confirm the diagnosis. As such they had no basis for 
giving it. This report was consistent with what was said in individual interviews where the 
criterion for use of magnesium sulphate was reported to be presence of convulsions.  
“Especially those who have convulsed and we are afraid they can complicate those ones we give 
them straight away and refer them because it is an emergency, so we do not wait. But we tell 
those patients with pre-eclampsia to go to the hospital for delivery when labour starts and never 
to come her”. Nurse midwife technician HC4 
“I have never seen one with pre-eclampsia being given magnesium sulphate. I am not even sure 
as to whether a patient with severe pre-eclampsia  who has no convulsion  is to receive 
magnesium sulphate” P 4 FGD 
“We are not giving magnesium sulphate because of the high BP, but there has to be protein 
positive in urine. So the reason why we don’t give at the health centre is that we do not have the 
tests for urine protein, so we are not sure whether the BP has just gone up.” P1 FGD 
 
4.2.3.2 Management of eclampsia 
According to the participants in this study, eclampsia was perceived as an emergency and was 
dealt with, with urgency. Both reports from individual interviews and FGD revealed that patients 
with eclampsia were put on intravenous fluids, catheterized and properly positioned to ensure 
clear airway and to prevent them from injury. Some participants stated that they gave the patient 
a first dose of magnesium sulphate to control the convulsions and then referred her to the hospital 
for further management. They also stated that monitoring of the blood pressure, fetal and 
maternal conditions was done while awaiting transport to the referral facility. However some 
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participants were not comfortable with the use of magnesium sulphate and thus opted to use 
valium (Section 4.2.5).  
4.2.4 Perceived benefit of pre-referral care  
Health care providers reported of more benefits than detriments to the care provided to patients at 
the health centres prior to referral to the hospital. The majority reported that the pre-referral care 
reduced further complications to the mother and the expected baby; hence reduced maternal and 
perinatal mortality. They also reported that the care enhanced management of patients and 
reduced workload for their counter parts at the referral facility. Most of all, they felt it was a way 
of fulfilling their responsibility as first level care providers. Explain how they perceived the pre-
referral care, these midwives said, 
“We would be failing our duty as a health centre if we just send the patient without doing 
anything. When we are referring a patient at health centre we do have pre-referral treatment, 
treatment before referral. It is our responsibility as health centres that if we are referring a 
patient to the central hospital we are supposed to do a few things which we can manage as a 
health centre. The rest will be done at the big hospital. If we don’t do anything then it means our 
friends will be busy there doing basic things. The treatment we give here helps the patient to get 
there in a good condition somehow”. 
Nurse midwife technician HC3 
They benefit because it saves their life. There might be some complications, yes, but if there will 
be need for let’s say operation, at least the must both be alive, the mother must be alive and the 
baby must be alive. 
        Nurse midwife technician HC5 
 
4.2.5 Challenges in the management of patients with pre-eclampsia and eclampsia at the 
first level facility 
Participants from the individual interviews and the FGD identified many challenges that could 
explain why some patients arrived in a poor state at the referral hospital. These challenges were 
grouped into four categories; those that relate to the patient herself, those that relate to the health 
care provider, those that relate to health facility and those that relate to administration.  
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4.2.5. 1 Challenges related to the patient 
Some participants implicated patients’ delay in reporting to the hospital and non-compliance to 
referral as factors that condition of the patients. As this health care provider laments, 
“But there are some when you tell them to go to Queens they just go home and stay, they even 
stop attending antenatal care, they just come unexpectedly, checking her blood pressure you find 
it high, you check the notes you find that you already referred her but because she thought that 
she cannot manage to go there” Nurse midwife technician HC1 
 
4.2.5. 2 Challenges related to health care providers 
Challenges reported as hindrances to proper management of patients with pre-eclampsia and 
eclampsia were as follows 
 
a) Rarity of the condition 
Most participants and the overall sentiment of FGD participants was that pre-eclampsia and 
eclampsia were rare conditions that they might meet once in a while. As such they felt 
incompetent when faced with the conditions. They were more concerned with the management of 
eclampsia than pre-eclampsia, because they thought it was easier to deal with pre-eclampsia 
because it just required referral to the hospital during antenatal care; as opposed to eclampsia 
which required emergency obstetric care.  
 
b) Uncomfortability with use of magnesium sulphate 
Even though the majority said that they used magnesium sulphate on patients with eclampsia, 
there was limited knowledge and comfortability with its use. Most of the health care providers 
reported that they depended on guidelines and support from colleagues to administer the drug. 
Some participants (n=2) confused it with antihypertensive drugs. As a result they combined it 
with diazepam. The main source of their discomfort was reported to be fear of magnesium 
sulphate side effects and lack of the antidote. The fear was based on theory other than actual 
experience with its use. Expressing uncomfortability these health care providers had this to say: 
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“After putting up a drip we give her diazepam injection, instead of Magnesium Sulphate. There 
are some who went to learn about magnesium sulphate but not us. Yes, when they came back they 
were explaining to us but for me I should not lie I didn’t get anything. 
Enrolled nurse midwife- HC 11  
“I cannot say that I have been very comfortable until I am taught properly and adequately. 
Because the knowledge I have you see; is from school. So if I can know properly, I have been 
adequately reminded, I can give magnesium sulphate well because I know that the person will be 
helped” 
Nurse midwife technician- HC 6 
“So, we first give her a first dose Magnesium Sulphate intravenously then intramuscularly and if 
need be we also give her Diazepam there and then. Then we put her in the ambulance and send 
her to Queens” 
Nurse midwife technician- HC 4 
 
On the other hand, some participants expressed great comfortability with the use of magnesium 
sulphate. However, it was later observed that this group of participants had previously worked at 
a district hospital or they did locum at the referral hospital; as such, they were experienced with 
use of magnesium sulphate. Conversely, some of the participants who reported using magnesium 
sulphate for patients with eclampsia had not actually administered it in the real situation; they 
were basing the management on what they learned in college or on what guidelines stated. 
It was also observed that some health care providers were not able to comply with guidelines. In 
two health centres, they had a patient convulsing in their presence while waiting for ambulance to 
take the patient to the hospital, yet the patient came with a history of having convulsed at home. 
 
“she came with blurred vision, she could not see properly; until she started convulsions while we 
were waiting for  ambulance…. Because she first fitted at home, and she fitted here too.” 
Enrolled nurse midwife HC1 
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“She was brought here from home because she had convulsions. She had three episodes of 
convulsions at home. It was at night and it is far to bring her from home to here; however the 
time they found me here she was not convulsing. She just arrived, then I started taking history 
whether she has ever had convulsions before, and I checked the BP, all these I was talking to her 
without any problem. Later in the middle of history taking, she started having the convulsions”  
Nurse midwife technician-HC 2 
 
4.2.5.3 Challenges related to health facility’s capacity to handle cases of pre-eclampsia and 
eclampsia 
The participants reported many factors related to the health facility which could contribute to 
improper management of patients with pre-eclampsia and eclampsia as follows: 
a) Lack of essential material resources 
The majority of the participants reported lack of resources as one of the factors that constrained 
their efforts in the management of patients with pre-eclampsia and eclampsia. The resources 
included blood pressure machine (apparatus), urine protein dipsticks and antihypertensive drugs.  
Except for two private health centres, all health centres reported that lack of blood pressure 
measuring machines was a big problem. Some of the health centres, who happened to possess a 
blood pressure measuring machine at the time of study, reported that they had just acquired it 
recently or it was borrowed from colleagues doing some research within their health centre. Some 
participants reported that due to lack of blood pressure measuring machine they were forced to 
send patients suspected of pre-eclampsia to private clinics located close to the health centre to 
have their blood pressure checked. Other participants reported that they sent every pregnant 
woman with edema of the feet to the referral facility for blood pressure check and confirmation 
of the diagnosis. Realizing the importance of the blood pressure machine these health care 
providers stated: 
“..in my understanding  I find  pre-eclampsia to be so disturbing, but  I can say that I understand 
it well. It is just that from experience the main problem that we have here is lack of BP machine 
hence we do not know some things, we just base on other signs.  We also don’t do some tests at 
our level… if we have cases it means we just suspect that it’s high BP and if we suspect, then we 
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just refer to Queens, reason being we don’t have any BP machine”  
Nurse midwife technician HC 10.   
“As I have already said that we don’t have a blood pressure machine, so if its preeclampsia, for 
us to know that it is pre-eclampsia, that is she has not fitted okay, she may come with swelling, 
she will look swollen up. There is a clinic close by so we send them there to have their BP 
checked and give us feedback”. 
Nurse midwife technician HC7 
 
Similar problems concerning scarcity of blood pressure machines also emerged from the FGD. 
Another challenge was lack of urine protein dipsticks. All participants except two from one 
private clinic reported that they had no urine protein dipsticks in the health centres. 
Lack of antihypertensive drugs was also reported by participants from both individual interviews 
and the FGD. With the exception of the two private health centres, all of the centres had no 
antihypertensive drugs and they bemoaned that this made their care incomplete because they did 
not tackle the main problem in pre-eclampsia and eclampsia, which in this case is the elevated 
blood pressure. This what the group said; 
“Drugs like hydralazine are not available at the health centre, which is a very big problem we 
meet. Because with hydralazine we are fighting the rising of the BP (blood pressure), the cause of 
the convulsions is the BP. So even if we give her magnesium sulphate, we still feel that where she 
is going even on the way she may continue having convulsions”. FGD 
 
Other resources also reported included oxygen cylinders, airway devices and spatulas (Table 4)  
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Table 4: Resource availability in the 11 health centre 
Item availability of reasources out of ( 11) 
Health Centre  
Blood pressure measuring machine 5 
Stethoscope 11 
Thermometers 6 
Intravenous fluids 11 
Magnesium sulphate 11 
Hydralazine 0 
Protein dipsticks, 0 
Bladder catheters 10 
Urine collection bags 1 
Oxygen cylinders 1 
Suction machine 11 
Spatula 1 
Airway devices 2 
 
b) Shortage of staff 
Another reported problem was shortage of staff. Most participants reported that management of 
eclampsia requires team work but it was difficult for them because in most cases they operated 
alone. The participants stated that due to shortage of staff, patients with severe pre-eclampsia and 
eclampsia were not accompanied to the referral hospital by a health professional on referral; they 
just went with a guardian, and sometimes with a cleaner. Reports from FGD were also similar 
with this report.  When asked on patient safety and escort this is what was reported: 
 
“On the safety issue, the problem is that this patient is supposed to be under escort, in case the 
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patient has some mouth secretions, since the patient is sedated. But it is difficult because this is 
not the only condition that needs escort, there are other conditions like cord prolapse and the 
like, they are supposed to have escort. Escort, we may say a nurse should go, but because of 
shortage, you find that the nurse is all alone in the labor ward, if she goes, who is going to man 
the labor ward? Okay, let us say the person has come at the time when the labor ward is well 
staffed; the nurse will go, but how is she going to come back?”Nurse midwife technician HC 10 
 
c) Transport problems 
Delay of ambulance was also reported by health care providers as one of the major challenges in 
the management of patients with severe pre-eclampsia and eclampsia. Participants, except for 
those working in private health centres, expressed concern over the delays of ambulances. The 
participants stated that on average the ambulance took three to four hours before arrival after it 
had been called. It was reported that there was only one ambulance that was stationed at the 
district health office that ferried patients from all health centres, and consequently, it was difficult 
for the patients to be collected and ferried to the hospital on time. It was also reported that most 
often the ambulance came already full with patients, so much that it was so difficult to put an 
eclamptic patient in the proper lying position. Furthermore, the transport problem was also 
reported as to having contributed to health care providers’ inability to escort critical patients, as 
observed in the first quote (HC10) above. Bemoaning transport problems one of the health care 
providers concurring with the other members of the FGD narrated: 
“Because a real ambulance is supposed to have everything inside, but if you observe you see that 
when they are coming they remove the oxygen cylinder, they remove what, every necessary thing 
is removed, and they say that they want to load many (patients). So it happens that the ambulance 
you have called is coming from other health centres, is full. So much that even for you to lay 
down the eclamptic patient it becomes difficult, ...”  
FGD 
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4.2.5.4 Challenges related to health centre administration 
The major issues stated in relation to administration of the health centres were two fold; limited 
supervision and lack of feedback from the referral facility.  
a) Lack of supervision in the management of patients with pre-eclampsia and eclampsia  
Health care providers reported that they received general supervision but no supervision for the 
management of patients with specific complications like pre-eclampsia and eclampsia. They also 
expressed concern over the manner in which the general supervision was done as illustrated in 
quotes below. 
 “To say the truth the only supervision we get is when the matron comes, but not coming just for 
pre-eclampsia patients. May be they depend on the state registered nurses, like here we have one 
and she is the one who assists. There is no support supervision from DHO [Department of Health 
Office].” Assistant physician -HC3 
“As my friends have already pointed out that it is like fault finding, and when they find the fault 
they fire on you, forgetting that we cannot work if we do not have the resources FGD 
“You find that if they find you outside, they shout at you right there. “Must I be disgraced in the 
presence of my neighbor who might have come for antenatal care? No” FGD 
 
One participant expressed that supervision would help to ensure a uniform management of 
obstetric complications in the health centres as can be observed by what this health care provider 
said: 
“Supervision would ensure uniformity in the management of the patients. But you find that in the 
same district people are managing same conditions differently, all because we do not have a 
chance to come together as people of the same program to discuss or refresh on how we go about 
different conditions. Such refreshers would also help to remind some of us of the things we forgot 
long time ago. Yes, we are human beings okay, and in the course of our work we always wish to 
ask someone; and there are other things which you consult books, so if it were possible to be 
reminding each other some of these things it would be helpful.” Nurse midwife technician HC4 
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b) Lack of feedback from the referral facility 
There was very little feedback that health centres received from the referral hospital regarding the 
patients they referred. It was reported that in most cases the feedback was negative over the two-
way radio communication system (Motorola) or during maternal death audit meetings when 
deaths are being reviewed. To this effect, the health care providers at the two facility levels 
reported: 
“At times it’s [the feedback] on the phone, arguing over having sent a patient after being told not 
to. I remember one time, a certain doctor called to ask why something was not done on a patient. 
They exchanged words, it wasn’t a nice scene, and especially for patients to have heard such 
unprofessional conversation; the other person ended up crying. It was over the Motorola”. 
Medical assistant-HC 1 
“The main feedback is [from] the patient when she comes back and has come for checkup, that’s 
when she says “sister, do you remember me? You sent me and they helped me like this, the 
person herself telling you when she comes back. But not like a referral centre informing us, I 
cannot lie.  Otherwise, you just see the nurses’ council has arrived, and start telling, you, “you 
assisted such and such a woman on this day”, and you start wondering, “such a woman? I see 
many women”, meanwhile you would have forgotten about the patient, you see?”  FGD 
 
c) Perceived benefits of feedback  
The health care providers were of the opinion that feedback would give them an opportunity to 
learn from specialist feedback for the cases they refer to the hospital, since most often the patients 
were sent on an assumed diagnosis of pre-eclampsia or eclampsia due to lack of laboratory 
investigations. Furthermore, they stated that feedback would motivate and give them job 
satisfaction during the course of their work. When asked what they perceived as the benefits of 
patient feedback, these providers said: 
“Feedback would help to give us knowledge that ooh what I did was right because sometimes 
experience is what teaches us a lot. Sometimes you learn in class but if you meet the thing, 
experience and manage it, you see that okay, next time I will do the same”.  Nurse midwife 
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technician- HC6 
“It could be encouraging to us that we are really working well, we managed to help and refer the 
patient and where she was referred, she has received the appropriate care, and she is alive and 
well so is the baby. It would make us feel confident that we are doing the right thing, because our 
aim is to have a live mother and live baby. Losing a mother and baby isn’t nice, it’s not amusing. 
It portrays an image of not knowing what one is doing.” 
Nurse midwife technician HC 1 
 
4.2.6 Suggestions for improvement 
The participants suggested that there is need for adequate resources such as low beds, enough 
medicines such as Magnesium Sulphate, antihypertensive drugs, enough spatulas and working 
blood pressure machines. They also suggested the need for improved communication between the 
health centres and the referral hospital. They also mentioned quarterly supportive supervision and 
refresher courses on management of pre-eclampsia and eclampsia.  
When asked what they would suggest for improving the care of patients with pre-eclampsia and 
eclampsia, they said, 
“We must at least have adequate resources. I don’t know whether we are allowed to have oxygen 
in health centres, but it can help us. Because even with resuscitation of the baby in case she 
delivers the baby will be asphyxiated secondary to the mother’s convulsions, so an oxygen 
cylinder will be helpful. And also the calcium gluconate, we are talking about that may be while 
waiting for the ambulance which might be delayed, if anything goes wrong we can give. And 
antihypertensive drugs like methylodopa and nifedipine, because hydralazine also has its own 
problems because it requires close observation too because it can bring down  the BP abruptly” 
FGD 
 
4. 3. Interviews with health care providers at referral facility 
As stipulated in the previous chapter on methods, interviews were conducted with eight health 
care providers at the referral centre, i.e. Queens..., to better understand the condition of patients 
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on arrival at this facility level in relation to the care they received at the first level facility. The 
study also sought to understand health care providers’ perceptions about the challenges that their 
counter parts face at the first level facility. In this section of the findings, results pertaining to 
interviews at the referral facility are presented. Issues which were explored included their 
understanding of pre-eclampsia and eclampsia, their assessment and perception of the patients’ 
condition on arrival to the referral facility, what they perceived as benefits and barriers to proper 
management of referrals at their facility and suggestions for improvement. In the first section 
demographic information of these participants is presented. 
4.3.1 Health care providers’ understanding of pre-eclampsia and eclampsia 
The health care providers, like their counter parts at the first level facility of care, were asked to 
describe what they understood about the two conditions of pre-eclampsia and eclampsia. These 
health care providers had better understanding of the conditions. The health care providers were 
also able to mention all defining characteristics of the two conditions as conveyed in their 
descriptions below: 
 
“It is a condition of high BP in a woman who is pregnant but has not started fitting. When it is 
an ordinary high BP, urine protein is negative, and does not have signs like edema of the legs, 
urine protein is okay, the BP just goes up, and it is just ordinary BP. But for people with 
preeclampsia and eclampsia, they can have all those signs, high BP, swollen legs, urine protein 
is also positive.  And eclampsia is when BP is high but she has also started to fit”.HCP 3 
“Preeclampsia is when a woman is pregnant but has high blood pressure, and when you test her 
urine there are proteins. Eclampsia is when the woman has blood pressure, has proteins in 
urine but now she has fits, is fitting” HCP 4 
 
4.3.2 Patients’ condition on arrival as assessed by health care providers at referral facility 
The health care providers were asked to describe the patients’ conditions on admission before 
they rendered any care to them. They reported that there was generally inadequate care offered to 
the patients before they were referred to the referral facility. While some patients received first 
aid treatment, some patients arrived without having received any. Patients who were reported to 
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have received first aid management were those who had eclampsia. Except for two patients who 
were referred from private health centres, none of the patients with severe pre-eclampsia received 
any first aid management (Table 5).  
 
Table 5: Pre-Referral Care of the 8 Patients included in this Study 
Item No. of patients who received stated care out of 8 
BP checked 6 
Temperature checked 3 
Pulse rate checked 2 
Respiration checked 1 
Bladder catheterization done 2 
Urine protein checked 0 
Intravenous  infusion 4 
Magnesium sulphate given 4 
Valium given 1 
Hydralazine given 0 
Other antihypertensive( given) methylodopa 
and HCT 
2 
Ensured proper position in transit to hospital 0 
 
The pre-referral care that was commonly reported included intravenous infusion, magnesium 
sulphate loading dose and rarely catheterization. It was also reported that none of the referred 
patients were accompanied by a health care provider. Two descriptions are provided to illustrate 
the conditions of patients upon arrival: 
 
“At the time I was admitting her she was complaining of headache which started on the way to 
this hospital, she was awake, but her whole body was swollen up, she had no iv litre, she had 
received panadol, diazepam and aldomet, and  at that time her BP  was very high, 225 over 
145”. No catheter, inserted, no albumin checked.  They were supposed to put her on a litre and 
insert a catheter to monitor intake and output. 
HCP 2 
“This patient I just found her on the trolley, another nurse told me that there was a patient on 
the trolley with eclampsia referred because she had convulsed at home. When I was preparing 
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to take this patient on the bed, when I checked her, I found that the patient was cold, no 
heartbeat, so that’s the condition. But before coming here this patient, she convulsed at home, 
and after convulsions she went to the health centre. At the health centre they referred that 
patient here. But as she was arriving, she was already dead”. “She had an intravenous infusion 
line but had no catheter. And they wrote that she received Mag sulphate, she received 
Magnesium sulphate 4gm iv, and magnesium sulphate IM, as a loading dose”.    “[….]” “ No, 
she just came with the driver; no midwife escort” HCP 5 
 
4.3.3 Perceived effects and benefits of pre-referral care at referral facility level  
The health care providers were asked to state how the pre-referral management of the patients 
impacted their management. The perceptions about the care were mixed. Some participants were 
satisfied with the pre-referral care while others were dissatisfied with the care, as illustrated in the 
narratives below. 
“It helped us because the patient had stopped convulsions, I did not even know that she was an 
eclamptic patient, she came walking. A group a patients just came at once by ambulance,  so it 
was the drip that she had that got my attention, so I said to myself, “ah, this one must have a 
problem”, so I called her that  “ come here, let me see your paper”. HCP8 
“I feel that it gave us much pressure even though we are not supposed to have pressure when a 
very sick patient comes to us, right? But we saw that the patient was delayed, because if she had 
come with at least a bit lower manageable BP, we could have just managed and then wait for 
her to deliver normally, it would have been better, but because she came in a very critical 
condition so it drew attention. Everyone had to stop whatever they were doing to assist the 
patient”. HCP 7 
 
4.3.4 Perceived barriers to proper pre-referral care 
The health care providers at the referral facility level were asked why they thought patients were 
inadequately managed prior to being referred. There were similarities in what all the participants 
stated as challenges at the health centre. The reported perceived challenges included shortage of 
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staff, lack of resources, limited knowledge, and problems with transportation of patients, as 
reported in the narratives provided below.  
“..health centres do not have their own ambulances,  so it happens that it has been called by 
health centre 1, 2,..  it is upon the driver to decide where to start from,  then where, because 
most of the times many patients come at once but coming from different health centres. HCP 4 
“It is just that in health centres sometimes we don’t have BP machines. I am also one of the 
health centre staff, I don’t belong here. So sometimes we just examine the people, provided we 
do a vaginal examination, whether they have high BP we don’t know. Really, we just examine 
the other things and then write “no BP machine” at the bottom, and refer her here where they 
diagnose the rest. We miss a lot at the health centre.  Unless it is now eclampsia, that is when 
we realize that “ii so this person had high BP”, and then we refer her. But it is just that we 
don’t have the tools to diagnose a person.  Because, supposing they had a BP machine, they 
would have checked her and see what her BP was”. HCP 1 
 
4.3.5 Suggestions for improved pre-referral care for patients with pre-eclampsia and 
eclampsia 
The health care providers made several suggestions for the improvement of care for patients with 
pre-eclampsia and eclampsia. They suggested the need to provide health centres with adequate 
supplies such as blood pressure measuring machines, urine protein dipsticks, antihypertensive 
drugs and magnesium sulphate. They also suggested that there was need for health care providers 
at the health centres to be updated on the current management of pre-eclampsia and eclampsia, as 
well as to have exchange programmes to allow them to practice the management at the referral 
facility. As much as they appreciated that shortage of staff was a general problem in the country, 
they still suggested that there was need to increase human resource at the health centres. On the 
other hand, they suggested that critical patients, like eclamptic patients, need an escort to prevent 
further complications. Asked to make suggestions for improvement, this is what they said,  
“I would like in-service or refresher courses on management of preeclampsia and eclampsia. 
For them to know what they are supposed to do before referral. Because such a person is at risk 
of convulsions. She can end up with eclampsia anytime. So they must do first aid treatment that 
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at the receiving point or in transit the person must not be at risk of convulsing or that at least 
where she is going they must have a starting point. They must at least put up an iv line, catheter, 
and that will help. On the other hand the supply of  equipment must bereadily available, like 
urine dipsticks and catheters”HCP 6 
“I feel that if they could be given specimen bottles to collect blood. When they refer the patient 
they must get blood specimens that are required from a patient with high BP, it would be better. 
And also   catheters and things for testing urine for protein so that they can do everything for 
the patient and here we just continue the care of the patient. They must also be given enough 
drugs like magnesium sulphate, and also there must be enough nurses at the facility, so that one 
can be managing other patients while this one is also being managed…. It is also necessary that 
the nurses from the health centres they must have an exchange program, for them to come here 
at Queens to work to see how we manage these patients”HCP 3 
 
4.4. Interviews with patients and guardians 
4.4.1 Introduction 
As was stipulated in the previous chapter on methods that patients were included in this study as 
a criterion to selecting health centres to be included in the study, as such only six interviews were 
conducted with patients who had been referred from the health centres due to pre-eclampsia and 
eclampsia in the first month of the study. Two guardians were included as patient participants 
because their patients were not in a state to talk let alone remember what actually happened to 
them due to eclampsia. The patient participants were asked: 
a) What symptoms made them seek medical care 
b) How they were treated at the  health centre 
c) How they felt to be referred to the hospital 
d) How they travelled to the hospital 
e) How else they  would have liked to be  cared  for before referral to the hospital 
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4.4.2 Recognition of problem 
Patients were asked to describe symptoms which made them to seek help at the health centre and 
what they thought was the meaning of the symptoms. The results showed that all six participants 
were unable to relate the signs and symptoms to pre-eclampsia and eclampsia before diagnosis 
was made at the antenatal clinic. One patient associated her symptoms to the sex of the baby she 
was expecting. Another patient associated the signs and symptoms to being term and due for 
delivery of the baby. One patient thought they were signs of malaria. One guardian just did not 
know what was actually happening with her daughter. When asked why they went to the health 
centre some said; 
 
“No, there wasn’t any problem that I saw; I just stayed just like a person…this swelling problem, 
others told me that when others are expecting   a male baby they swell legs or arms. When it is a 
female baby some may also swell legs or arms. So in my case the female child that I have, I did 
not swell. So with this male one, I was found with this swelling problem, but the problem is that it 
was my whole body that got swollen”Patient -1 
“Some people told me not to worry about it, because it meant that I was going towards delivery 
days, some were saying that, like my neighbours” Patient-4 
“For me, I didn’t know what the problem was really, me too I was just feeling scared that, 
“should a pregnant person be fainting?” Guardian to eclamptic patient-6 
 
4.4.3 Pre-referral care at the health centre 
Patients and guardians were able to narrate the care they received at the health centre before 
being referred:  
“when I arrived, I arrived at their maternity ward, then they started asking me questions about 
what I was feeling, I started explaining that at night I didn’t sleep well I just felt lower abdominal 
pains, so they put me on a bed and checked if the baby was still beating and they palpated my 
abdomen to find the baby’s position, and they measured my BP and that’s when they found that it 
had risen a lot. So there they don’t have some equipment, also they don’t have some medicine 
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nearby, so I must just go straight to a big hospital, that’s when we were coming here” 
Patient-5 
“When we arrived at the hospital, they welcomed us very nicely and helped us. Whilst we were 
there she fainted again. That is when they told us that,”you cannot stay here, we can’t do 
otherwise, you must go, we will call for an ambulance to come”, when they had put her on a 
water drip that is when the ambulance arrived… they gave her some medicine because they 
injected her, right there and put her on another water drip” Guardian to eclamptic patient. 
Apart  from two patients who were referred from the two private health centres, the other two and 
the two guardians could not say what  type and purpose of the drugs that was given to them, 
which may indicate lack of explanation  on the part of the health care providers.    
4.4.4 Compliance with referral  
All participants reported that they were happy with the referral because they knew that the 
referral hospital had more resources and specialists to take care of them. One patient had this to 
say; 
 
“There was no problem because at the hospital where I went they don’t have a scanning 
machine, they don’t have electricity. So I felt that it is good to come here so that they can see 
what the problem is”.Patient-2 
 
4.4.5 Transportation 
All patients reported that they were transported by ambulance from the health centres to the 
hospital. However, three patients reported that there was some delay with the ambulance, either 
on arrival to the health centre or en route to the referral hospital, as can be learned from the two 
narrations below: 
 
“Considering the time we arrived and when the ambulance was called, I think it came quickly.  
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But the travelling was that from there it went to [  ], from there it also stopped at the hospital in [ 
] , so in all those places we stopped;  the drip even run out on the way”  
Guardian to eclamptic patient-6 
“The ambulance was called around ten in the morning. …it came around six o’clock and we got 
here around 8 o’clock.  Because the time I got there I found another    patient waiting, it is the 
ambulance that delayed to come.  They had to call for the second time, which is when it came in 
the evening” Patient-2 
 
4.4.6 Patients’ satisfaction with pre-referral care 
Participating patients and guardians were asked to express how they felt about the care they (or 
their loved ones) received at the health centre and to make suggestions for improvement. Four 
participants were satisfied with the care they received. One guardian was satisfied but was of the 
opinion that it was not upon her to judge the care her daughter received at the health centre 
because the health care providers knew better than her, so she could not tell them what to do. 
Asked what they felt about the care and how satisfied they were, this patient and guardian said 
this: 
“…as you have seen that when I came with the child, I thought that I will sleep in the room with 
her right? But to find out that they said I should go back home, so I don’t know how things were 
during the night”. Guardian 2 to patient 3 with eclampsia 
“..it was the fact that they told me to go to Queens when the time was up already, but the doctors 
at my place didn’t explain anything to me they were just looking at me (almost crying). They 
were doing things like, if you want them to assess you, you have to ask them to”.Patient-4 
 
4.5 Summary of findings 
The findings of this study can be summarized as follows: 
a) Every health centre visited had health personnel who knew how to manage a patient with 
pre-eclampsia and eclampsia. However, they were understaffed and limited by lack of 
essential resources and this compromised the quality of services provided. 
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b) There was noncompliance to guidelines as demonstrated by nonuse of magnesium sulphate 
on cases of severe preeclampsia by the health care providers at the first level 
c) First level health care providers received limited supervision for obstetric complications and 
they had little or negative feedback from the referral hospital only. 
d) Health care providers at the referral facility acknowledged the challenges faced by first 
level health care providers 
e) Patients in this study had limited knowledge about pre-eclampsia and eclampsia.Analysis of 
the findings in this paper have been presented using descriptions which have been 
supported by quotes from the interviews and focus group discussions. Quotations have been 
usedto explainorillustrate to deepen understanding, to give participants a voice, and to 
enhance readability [53]. Tables have been used to present participant characteristics and 
observations on availability of resources. 
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CHAPTER 5 
DISCUSSION 
5.0 Introduction 
The previous chapter presented findings of this study. In this chapter, the main findings of this 
study are discussed. The first section discusses findings in relation to health care providers’ 
understanding of the two conditions which are followed by a discussion on challenges that might 
hinder proper management of patients with pre-eclampsia and eclampsia at the first level facility 
of care and which possibly explain why some patients arrive in a compromised state at the 
referral facility. 
The main objective of this study was to explore first level health care providers’ perspectives on 
the management of patients with pre-eclampsia and eclampsia before referral to the tertiary 
facility. Even though the findings may not be generalized due to the inherent nature of qualitative 
research and methodologies used, the small samples involved and the limited time taken to 
collect data, the study has revealed several issues that potentially affect care of patients at the first 
level facility. The qualitative approach that was used to collect data in this study helped to deeply 
understand the context in which health care providers managed patients with pre-eclampsia and 
eclampsia and the triangulation of methods allowed for corroboration and confirmation of 
converging perspectives thereby representing a more accurate picture of reality. 
 
The study showed that the quality of pre-referral care for patients with pre-eclampsia and 
eclampsia was generally substandard and was inconsistent with best practices.  The results 
highlight five main factors that contribute to pre-referral substandard care of patients with pre-
eclampsia and eclampsia at the first level facility of care. They include: inability to put 
knowledge into practice, lack of basic essential resources, shortage of staff, transportation 
problems, lack of supervision, and inability of patients to recognize pre-eclampsia and eclampsia  
5.1. Inability to put knowledge into practice 
Although health care providers demonstrated great awareness of pre-eclampsia and eclampsia 
and moderate knowledge for the management of these conditions, they were not able to apply the 
knowledge let alone the guidelines into real situations.  While the WHO uses the presence of 
skilled birth attendants (SBA) as an indicator of progress towards reducing maternal mortality 
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worldwide, their mere presence alone may not translate into practice [59]. There is need to ensure 
skill competence for better results.  In a study to assessed SBA competence in five high maternal 
mortality settings as a basis for initiating quality improvement, there was a wide gap between 
current evidence-based standards and provider competence to manage selected obstetric and 
neonatal complications. The study was done in two phases; first phase included 166 purposively 
selected providers in Benin, Ecuador, Jamaica and Rwanda and in phase two 1358 providers from 
tertiary, district and primary health facilities in Nicaraguan. The researchers reported that 
participants from both phases of the study did not recognize diastolic reading of blood pressure 
that defines severe pre-eclampsia and the right approach to management of this condition. The 
mean scores being knowledge and management of pre-eclampsia were 63.1% and 51.2% in phase 
one and two respectively. In the same study nonprofessional nurse midwives scored lower than 
the doctors and student doctors [59]. Similarly, in the present study, health care providers were 
aware and able to recognize patients with pre-eclampsia but were unable to manage them 
according to guidelines for evidence based practice. Women detected with mild hypertension 
were advised on rest and sent home.  
 
One characteristic of mild pre-eclampsia is its tendency to unpredictably rapidly progress to 
severe pre-eclampsia and eclampsia [5]. As such, sending women with mild pre-eclampsia home 
invariably exposes them to risk of eclampsia because these women have limited possibility for 
rest. According to essential best practices and basic maternal and newborn care guidelines, all 
pregnant women with pre-eclampsia regardless of severity of the blood pressure, are supposed to 
be referred to the hospital for specialist care, unless proven to be ordinary hypertension [11; 48].  
Non-adherence to recommended practice was also observed with nonuse of magnesium sulphate 
for patients with severe pre-eclampsia in this study.   In spite of considerable gains associated 
with the use of magnesium sulphate [42; 51], nonuse of magnesium sulphate still exists in most 
countries. In a study done in 20 of 32 states in Mexico, only 33 of  68 eligible women who died 
from severe preeclampsia and eclampsia received    magnesium sulphate and the rest of them got  
no anticonvulsant at all [60]. A study with an objective to observe pregnancy outcomes in 
eclamptic and to explore the avoidable factors contributing to the adverse outcome was 
conducted at the Hayatabad Medical Complex in Peshawar, Pakistan. The researchers reported 
use of magnesium sulphate only in 12 of the 71 patients who were eligible for treatment with this 
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drug [61]. In the present study all patients with severe pre-eclampsia (n=4) who were referred to 
Queen Elizabeth Central Hospital (QECH) from health centres included in the current study did 
not receive magnesium sulphate. Nonuse of magnesium sulphate   for patients with severe pre-
eclampsia in the present study causes great concern, considering that patients with these 
conditions may take a long time to get to the referral facility due to long distances. The long 
distance and the potential delay are good enough reasons for giving a prophylactic dose of 
magnesium sulphate to prevent convulsions on the way [11].   
 
Another reason to give prophylactic magnesium sulphate is the fact that these patients do not 
have a professional escort to the referral facility to administer an anticonvulsant in the event of 
convulsions in transit.  Just to emphasize the importance of pre-referral magnesium sulphate for 
patients with severe pre-eclampsia, in this study, on two different occasions, patients with 
suspected severe pre-eclampsia convulsed in the presence of a health care provider while waiting 
for ambulance to take them to the referral hospital. If patients like these are given a prophylactic 
dose of magnesium sulphate, such incidents may be prevented or minimized [11; 42].  
 
 Reasons for none or underuse of magnesium sulphate have been reported elsewhere. In a study 
whose objective was to examine the factors that might affect the translation of randomised 
controlled trial (RCT) findings into policies and practice in developing countries: a case study of 
magnesium sulphate for pre-eclampsia; Aaserud [62], reported that licensing and drug 
availability; inadequate and poorly implemented clinical guidelines; and lack of political support 
for policy change contributed to nonuse of magnesium sulphate.  Similar findings were reported 
by the White Ribbon Alliance in Pakistan in a review paper on magnesium sulphate for the 
prevention and treatment of pre-eclampsia and eclampsia [49]. 
 
Nonuse of magnesium sulphate for severe pre-eclampsia in this study was attributed to fear of 
adverse effects, lack of antidote, and lack of urine protein dipsticks to confirm the diagnosis; even 
though these reasons may not be good enough for not giving a single dose of magnesium 
sulphate. While it is true that magnesium sulphate can cause adverse effects, these effects are 
very rare [42].  
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Whereas lack of guidelines has been reported by other researchers to deter use of magnesium 
sulphate [49; 60; 61;62], all health centres except two had guidelines on the management of pre-
eclampsia and eclampsia, as well as on proper administration of magnesium sulphate. However, 
proper training and monitoring for proper implementation could be lacking [60]. 
 
Training and opportunity for practice through working at the referral or district hospital need to 
be made available for health care providers working in health centres. This will help to clear 
misconceptions and fears about magnesium sulphate and help health care providers develop 
competence and confidence in its use. 
 
5.2 Lack of material resources 
The most basic but crucial resources lacking for the management of patients with pre-eclampsia 
and eclampsia in this study included blood pressure apparatus, urine dipsticks; and 
antihypertensive drugs. The  lack of blood pressure apparatus and urine dipsticks  in these health 
centres is worrying considering that  these are  simple and very basic resources, yet crucial for  
early detection of  women with pre-eclampsia and eclampsia. Screening of women with pre-
eclampsia is primarily done by blood pressure check and urinalysis for urine protein [10]. Blood 
pressure machine is one of the commodities in the essential package for quality antenatal care 
[63]; unavailability may suggest lack of commitment by the supervisors [62] The lack of these 
resources in the health centres implies that most women with pre-eclampsia are missed during 
antenatal care and that is detrimental to both their health and that of their expected baby. The 
importance of blood pressure apparatus and urine protein dipsticks  need not be over emphasized, 
given the number of women(n=182) referred from health centres with suspected diagnosis of  
pre-eclampsia in this study. It is of concern to observe that women are complying with the call to 
attend antenatal care, but do not receive the optimal care that is due to them [64]. In the present 
study, 99.3% of the women had ever attended antenatal care. 
 
However, a few factors may explain the scarcity of blood pressure machines. Firstly, it could 
result from supervisors’ failure to appreciate the importance of certain standards of care [62], 
such as blood pressure check for early detection of pre-eclampsia. Such standards may look 
simple and unimportant but may prove the only chance to prevent development of eclampsia and 
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consequential death [7; 42]. Sufficient attention needs to be given to availability of resources in 
these health centres to ensure proper management of patients with pre-eclampsia and eclampsia. 
On the other hand, lack of funding and dependency on donations for provision of important 
services like maternal health may also explain this lack of essential equipment and the 
consequential compromised quality of care for pregnant women [30]. In addition to this, the 
problem can also be self-inflicting through poor procurement procedures which result in purchase 
of poor quality blood pressure machines [64]. Poor quality things do not last; as such they prove 
expensive because they require frequent replacement, which would not be feasible in a resource-
limited country like Malawi. In addition to blood pressure machines, the problem of lack of 
dipsticks was also observed at the referral facility. This also causes concern given that referral 
centres are supposed to cover for shortfalls in health centres [7]. Barua et al[62] in 2011 in their 
study on facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-
eclampsia in 3 Indian hospitals, reported lack of most essential supplies and equipment such 
laboratory and diagnostic tools; monitoring facilities; essential medications, including 
magnesium sulfate; a functioning respirator; and essential staff as opposed to the lower secondary 
level facilities which had the resources but did not have adequately trained staff . In the present 
study, 79 patients with high blood pressures did not have confirmed diagnosis due to lack of 
protein dipsticks at the referral facility, which led to them being treated blindly. High caseloads 
that are generally experienced by referral facility levels might explain this lack of dipsticks [62]. 
 
Lack of resources as a barrier to provision of quality obstetric care is not a new finding by this 
study.  Kafulafula[65] in 2005, in their article on challenges facing nurse-midwives working 
towards safe motherhood in Malawi, reported that limited resources and shortage of staff 
compromised the quality of care given to obstetric patients in secondary level facilities and it 
impacted on the quality of education on nursing and midwifery students.  It is worrying to 
consider that since 2004 safe motherhood campaigns have been and are still going on in Malawi 
encouraging women to attend antenatal care and to deliver at the hospital with skilled attendants , 
yet the care that is offered may not be skilled at all due to lack of  resources. 
 
Lack of antihypertensive drugs in health centres was another drawback in the management of 
pre-eclampsia and eclampsia revealed by the present study. Hypertensive drugs are crucial in the 
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management of severe preeclampsia and eclampsia in order to control the blood pressure [7; 11]. 
The drugs of choice are hydralazine, nifedipine and methylodopa [63]. Lack of antihypertensive 
drugs in these health centres is a great risk for severe preeclampsia and eclampsia given that the 
commonest killer in eclampsia is cerebral vascular accident. 
 
In a review of maternal deaths from hypertensive disorders in South Africa, Moodley [44] in 
2007 reported that 50% deaths from eclampsia were due to cerebral vascular accident and that 
was attributed to poor blood pressure control both at facility level and in transit to the hospital 
[44]. This means that, all patients in the present study were invariably exposed to the risk of 
cerebral vascular accident, hence to death. It was however, beyond the scope of this study to 
establish why antihypertensive drugs were not found in health centres.  None of the participants 
in either the FGD or in-depth interviews could explain why hydralazine was not supplied to 
health centres. Nevertheless, there is great need for supply of these drugs to health centres to 
improve the management of patients with severe pre-eclampsia and eclampsia.  
.    
5.3 Shortage of staff 
Shortage of staff is a well-known problem in Malawi and has been acknowledged by the 
government [66]. The main reasons for shortage of staff include deaths, retirement, and brain 
drain [36]. The shortage of staff is very pronounced in rural health centres [36]. This may be due 
to the fact that most midwives are female and they tend to move to the cities following their 
husbands, as well as lack of a conducive working environment in the rural areas. In a study to 
identify factors for retention of midwives in Malawi, the participants in this study reported that 
being married with a husband living in the city and being female and single was a big barrier to 
work in the rural areas [67]. Single female nurse midwives felt insecure that they might end up 
not getting married if the accepted to work in the rural areas [67].  
 
The government’s efforts to improve the situation for the past 10 years include increasing the 
student intake in medical and nursing colleges, and recruiting retired professions to cover the 
nurse to patient ratio gap [36]; but the status core seems to remain the same. Critical shortage of 
staff is deterrent to better patients’ care both institutional and in transit to the referral facility.  
Team work is very crucial for prompt resuscitation of patients with eclampsia [11; 13]; which 
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was observed as impossible in this study due to shortage of staff.  Moreover, critically ill patients 
require escorts to ensure continued care in transit to the referral facility [44]; but it is unfortunate 
that in the current study critically ill patients were transported alone with a guardian or sometimes 
with a cleaner who do not have medical knowledge which potentially lead to unexplained in 
transit deaths. Substandard care as a result of shortage of staff has been well-documented by 
other researchers [23]. Hassan-Bitar and Wick [23[in 2006, reported that shortage of staff 
contributed to substandard obstetric care for women in a large referral hospital in Pakistan. Even 
though this study was done at a tertiary facility and with a bigger sample than the present study, 
the findings are similar. 
5.4 Transport problems  
A well-functioning referral system allows for timely transfer of emergency obstetric emergencies. 
Despite recommendations to improve communication and referral systems through placement of 
ambulances in rural facilities and introduction of bicycle ambulances to speedup transportation of 
women with obstetric complications [28; 38], the situation remains pathetically the same.  In this 
study, critically ill patients had to wait three to four hours for transport to the referral facility. 
What is more, as reported by one patient, the patients had to stop over in other health centres to 
collect other patients which on its own compounded the delay and compromised the patient’s 
condition.  Furthermore, critical eclamptic patients require specific positioning in order to prevent 
choking during convulsions [11; 13];   which makes it nearly impossible when an ambulance is 
full with other patients.  
 
Patient transportation problems have previously been reported by other studies in relation to the 
three phase model of delay associated with maternal deaths. Cham, et al,[68] in 2005,  in their 
study on maternal deaths in order to assess access to emergency obstetric care in rural Gambia, 
they reported that transportation difficulties were experienced by women with obstetric 
complications even after reaching the first medical facility due to lack of a readily available 
ambulance at the facility. They also reported that traveling time was prolonged for these women 
due to long distances, visiting of different health facilities, poor roads, and ambulance conditions.   
Similar experiences were reported by one guardian to a patient with eclampsia that they had to 
visit different health centres before getting to the referral hospital. Delays in getting to the referral 
facility may contribute to adverse outcomes of women and their unborn babies. Special attention 
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needs to be given to transportation issues in order to enhance accessibility to comprehensive 
emergency obstetric care and to reduce mortality from eclampsia. Limited attention to such issues 
of delay may suggest the slow progress observed towards achievement of the millennium 
development goal number five [4]. It must be noted that even with increased access to skilled 
attendants at birth [4], without proper backup mechanisms to facilitate referral of patients from 
first level facilities; women are likely to continue dying from complications of pregnancy.   
 
There are considerable gains that are associated with an improved functional transport system 
[69]. An intervention study to reduce the risk of maternal death associated with obstetric 
complication which was conducted in Mali between 2003 and 2006, the researcher reported that 
during the study period, the crude case fatality rate for maternal deaths reduced from 10.1% to 
5.13% [69]. Serious consideration needs to be given to improvement of transportation in order to 
improve the referral process and to reduce deaths from delays. 
5.5 Lack of supervision and feedback 
 Importance of supervision in delivery of health care services need not be overemphasized; it is a 
requirement not an option. Supervision ensures patients’ safety, prevents adverse effects and 
improves clinical outcomes. Furthermore, supervision promotes acquisition of competence and 
confidence for independent practice [70]. In this study health care providers reported receiving 
little or no supervision at all; and this had negative implications on care given to patients.  Due to 
lack of supervision in this study health care providers adhered to their old practices which 
compromised the quality of care given to patients despite availability of guidelines for new 
practices. It is necessary that health care providers at this setting receive supervision to ensure 
adherence to evidence-based practice. 
 
However, lack of supervision in the current study may be attributed to lack of financial resources, 
human resources and lack of knowledge on how best to do a proper constructive supervision. The 
findings on lack of supervision in this study support what was previously reported by other 
studies. In a study on health workers’ perspectives on improving motivation among primary 
health care workers in Tanzania, the researchers reported that lack of supervision and feedback 
demoralized health care providers and made them feel unappreciated [22]. Similarly, Hassan and 
Wick [23] in 2006, reported that lack of supportive supervision and limited knowledge of 
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evidence-based practice, and being subordinate made health care providers feel powerless to 
effect any change [23].  
 
On the other hand, lack of feedback from the referral facility in this study raised issues of 
professionalism and inter-facility relationships. Just like supervision, feedback creates a mutual 
understanding between two entities.  Giving feedback to health care providers at the first level 
facility will help them reflect and improve on their practices for the benefit of future patients. 
Similarly, if patient care is improved at the first level facility, congestion at the referral facility 
will be reduced because some cases will have been managed effectively at the first level facility 
resulting in less referral of patients. Additionally, well managed patients have improved 
outcomes at the referral facility. Unfortunately, the manner in which feedback is currently being 
given is unsupportive and unproductive and it demoralizes the health care providers.  
Demoralized health care providers cannot provide quality care to patients. Lack of feedback from 
referral facilities was also reported by Manongi, et al in2006 [22].  
 
5.6 Patients’ inability to recognize pre-eclampsia and eclampsia 
The inclusion of patient participants was not necessarily to evaluate the quality of care received, 
but to determine from where they were referred, ability to recognize problem, description of pre-
referral care that was received and their experience with referral. Even though there were only 
few interviews conducted with the patients, the information they shared was helpful with 
establishing continuity of care from first level facility to referral facility. In this study, therefore, 
it was observed that there generally seemed to be limited knowledge about pre-eclampsia and 
eclampsia at individual and community level. This may indicate that women are not educated 
about pre-eclampsia and eclampsia. Lack of awareness may contributor to delay in seeking 
appropriate medical help [44]. There is need to teach pregnant women on danger signs of pre-
eclampsia to help in early detention. 
5.7 Evaluation of the study 
This study has both strengths and limitations. The strengths are that the findings of the study have 
answered the research questions using qualitative research approaches. Triangulation was applied 
throughout the data sources, thus providing a self-validated data, findings and conclusions. The 
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study has clearly demonstrated the importance of triangulation in the social dynamic conditions 
prevalent in the field. Triangulation has also demonstrated how complex the management of pre-
eclampsia and eclampsia is and that further study is urgently required if health workers are to be 
assisted in the provision of first level health care to pregnant women. 
 
The complexity of the findings supports the argument for using different data sources. For 
example, it would not have been useful to ask the health workers at the health centres only to 
identify the challenges of managing pregnant complications, because the positive factors could 
have been exaggerated or even invented while negative factors would have been conveniently 
overlooked [71]. Furthermore, management of the conditions might have been taking place at the 
health centres which the health workers at the referral hospital were not aware of because such 
activities had taken place slowly over a long period of time. That is why concerns such as these 
were addressed by using semi-structured interviews for data collection from different key 
participants. Therefore, using one data source to collect data in these circumstances was not 
considered reasonable. 
 
The data is remarkably diverse, providing rich and complex findings on the management of the 
complications of pregnancy, which was demonstrated by key participants. At the same time, it 
was possible to identify a number of common issues or concerns, which emerged from different 
data sources. The commonalities of issues in the management of pre-eclampsia and eclampsia 
among health workers at the health centre and at the referral hospital were a positive outcome 
because they demonstrated the extent to which different health workers at different levels had 
similar perceptions concerning the management of  pre-eclampsia and eclampsia. 
 
On the other hand, the study design and methods that determined the sample sizes and sampling 
procedures of the health workers in Blantyre made the results generalizable only to participants 
who share similar characteristics and settings. In short, the findings of this study are tentative as 
they are inductively developed, prone to subjectivity and subject to modification through 
subsequent research findings. Similarly, although they may have a wider applicability in the field 
of pregnancy management, they can only be generalized to the sample under study. 
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Researchers of pre-eclampsia and eclampsia have tended to examine more at a single 
management level rather than the multilevel management of the conditions. Consequently, little 
had been done to establish how various levels of management influence each other in the 
provision of quality health care to pregnant women. For this reason, the researcher had to 
construct her own procedures, which were rigorously validated through pilot testing within the 
period of study. 
 
A number of questions arise from the methods used calling for an alternative approach if this 
study was to be conducted again. For example, investigating the management of pre-eclampsia 
and eclampsia using case study design of a centre would provide additional insight into centre 
activities and their usefulness in managing pre-eclampsia and eclampsia. A case study would 
involve an exploration of a case such as a “programme, an event, an activity, or individuals” (52) 
using different data collection methods, within a specific setting and time frame. Examining such 
cases would enable the researcher to look deeper into the nature of the management activities 
using additional data collection methods such as participant observation to describe the 
phenomenon in more detail. 
 
In addition, since first level health care seeks to manage the conditions before the patient is 
referred to hospital, gathering quantitative data in the form of test scores and qualitative data that 
explores management skills would provide a better understanding of the relationship between 
conditions and the care provided[59].  
In conclusion, the findings of this study are not in conflict with those of other earlier studies on 
pre-eclampsia and eclampsia. Instead, it offers a further dimension to the understanding of the 
complexity of the interplay among policy, theory and practice in the management of the 
management of the conditions, given the harsh conditions prevalent in primary health care 
systems in most developing countries such as Malawi. First level health care is more effective 
where health workers enjoy high professional and material support. The findings I have presented 
here are but a simplified theory that explains the complex process of the management of the pre-
eclampsia and eclampsia 
In the next chapter conclusion for this research will be done together with the recommendations. 
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CHAPTER SIX 
CONCLUSION 
6.0 Introduction 
In this last chapter of the paper, presentation of recommendations, conclusion and areas for 
further research is done basing on the study findings. 
6.1 Recommendation 
Basing on the crucial issues emerging from the current study findings and discussion the 
following recommendations are made. 
 It was observed in this study that health care providers have the knowledge but there are 
limitations in their competences. There is need for skill building among all staff that are 
involved in the management of patients with pre-eclampsia and eclampsia. This would be 
effective if it is coupled with regular monitoring   and supportive supervision.  Since 
eclampsia is a rare condition, health care providers may benefit from allocation to referral 
hospitals where these cases are common.  
 The study also revealed that there was scarcity of essential resources for management of 
patients with pre-eclampsia and eclampsia which compromised the care of these patients.  
The scarcity of some items like blood pressure machines in this study was partially due to 
poor quality of the items. There is need for health centres to be supplied with essential and 
durable essential resources for management of patients with pre-eclampsia and eclampsia.   
 Transportation is very crucial in prevention of deaths from delays in accessing emergency 
care. There is need for the authorities to seriously consider increasing number of 
ambulances to enhance speedy referral of patients to the referral facility. 
 The findings of the study revealed that health workers were rarely supervised in the 
management of patients with pre-eclampsia and eclampsia. Supervision of health workers 
at first level facilities is very important considering that some complications of pregnancy 
are irreversible and need handled with care. Proper management of patients with pre-
eclampsia and eclampsia at the first level of care has double gains; in that two lives will 
be saves. There is need for regular supportive supervision to ensure that health care 
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providers develop competence, not only in the management of pre-eclampsia and 
eclampsia but of other obstetric complications. 
 The study revealed that feedback was not given to first level health care providers for the 
patients they send to the referral hospital. The referral facility needs to give regular 
feedback to the health centres to help them reflect on the care they offer to patients. While 
it can be appreciated that doing that for every patient could be difficult, the critical near 
misses must be sources for learning opportunity for the first level health care providers. 
For example, instead of always doing a maternal death audit review, all crucial cases 
referred in a month can be compiled, and organize a refresher for health care providers at 
the first level basing on those cases. And this must be followed up to see how patients are 
managed following such focused refresher. Therefore, there is need for the referral 
hospitals to acknowledge the effort put in during the first level health service provision by 
health workers and provide the necessary feedback to encourage them to improve the 
services. 
 Shortage of staff is a long standing problem in Malawi, and was also reported in the 
present study. The government’s efforts to address the situation must be acknowledge. 
However, there is need to continue and intensify training of nurses midwives since they 
are the ones who are very few. 
 
6.2 Areas for further research 
In summary, the findings indicate that attention to understanding signs and symptoms of pre-
eclampsia and eclampsia as well as factors which precipitate the complication is an important 
area of further research. Patients’ knowledge and beliefs about such conditions within social and 
cultural context is an interesting and an integral part of the day-today management of the pre-
eclampsia and eclampsia. This research has several implications for the future. First, the research 
topic is certainly pertinent to the management of other types of complications arising from 
pregnancy in the patients’ homes, at the health centres and at the referral hospitals. While this 
study looked at first level management of the pre-eclampsia and eclampsia within one district, 
subsequent studies could just as effectively focus on other single districts.  With either research 
approaches (studying patients in their homes or replicating the study in another single district), 
there would be opportunity to synthesize a model perspective for the management of pre-
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eclampsia and eclampsia. The management model would allow for rich, descriptive insights to 
the research questions and should be considered in subsequent studies. Second, a study that 
focuses on how first level health provision ultimately affect the subsequent outcome of referral 
cases would be interesting. Such a study would include a longitudinal approach, following the 
dynamics of the handling process of individual patients until the referral was complete. The 
results of the longitudinal study could indeed provide a template of effective pre-referral 
management of the conditions by determining which strategies worked and which did not in 
relation to this study area. This type of study and the results lend itself to the area of applied 
health research. Third, other theoretical approaches to causes of pre-eclampsia and eclamspia 
could yield even more conclusive health provision results. For example, while many theories are 
based on quantitative scientific studies (focusing on numbers and frequencies), qualitative 
research approaches (focusing on words and actions), would bring another dimension of drawing 
on the patients’ experiences before, during and after pre-eclampsia and eclamspia. Fourth, the 
focus of the research questions in this study lends itself to data analysis from a critical 
perspective. An issue, such as power and the creation of meaning, should be studied from the 
perspective of what voices are not heard and/or marginalized in the management of pre-eclampsia 
and eclampsia. The data that results from this framework could provide for greater application of 
the findings for first level management of the conditions. Thus, a critical perspective could help 
in identifying suppressed voices and perhaps eventually result in greater patients’ participation. 
Finally, the scope of the research could be expanded theoretically to include the area of culture. 
Understanding individual health centres is more important than generalizing from a set of 
behaviors or values across organizations. Following this line of thinking, data from the current 
study could be analyzed in order to discover the values health workers hold and how these values 
in turn impact the meanings created. Data could further be analyzed in terms of the management 
performances present in the study. For example, the interviews and observations which were 
conducted in this study might be evaluated more closely in terms of organizational rituals. Other 
research questions that evoke a cultural perspective would be: How might the organization's 
existing culture impact the management of patients with pre-eclampsia and eclampsia? And how 
do the management of patients with pre-eclampsia and eclampsia ultimately impact the culture? 
The above ideas are representative of a few different directions for further research on this topic.  
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6.3 Conclusion 
This dissertation describes an investigation of factors the hinder management of patients with 
pre-eclampsia and eclampsia in health centres in Blantyre through the use of an open-ended 
interviews, focus group interviews and observations. The findings from this study are: health 
workers demonstrated to have enough knowledge about pre-eclampsia and eclampsia. However, 
they provided unsatisfactory first level care to the patients because of lack of resources and drugs, 
under staffing, poor transport for referred patients to hospital. A replication of the study reported 
here to a larger sample might yield different results. The implications of the problems and 
challenges identified in this study call for further research more focussed health care policies, and 
more support for health workers to improve the provision of first level care to patients with pre-
eclampsia and eclampsia. The findings of this study should be interpreted with caution because of 
the small sample size in the study and the fact that patients were not accessed to find their views.  
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APPENDIX 1: STANDARD MANAGEMENT OF ECLAMPSIA 
SHOUT FOR HELP. 
Urgently mobilize all available personnel. 
• Perform a rapid evaluation of the general condition of the woman, including vital signs 
(pulse, blood pressure, respiration) while simultaneously finding out the history of her present 
and past illnesses  from her relatives if available. 
Do not leave the woman on her own.  
 Help her into the left side position and protect her from fall and injury 
 Place padded tongue blades between her teeth to prevent a tongue bite, and secure it to 
prevent aspiration (do not attempt this during a convulsion) 
If the woman is unconscious: 
 Check airway and temperature; 
 Position her on her left side; 
 Check for neck rigidity, if present use appropriate isolation precaution to protect facility 
staff and other patients in case the woman has meningitis 
If the woman is convulsing: 
 Position her on her left side to reduce the risk of aspiration of secretions, vomit and 
blood; 
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 Protect her from injuries (fall), but do not attempt to restrain her; 
 Since every pregnant woman with convulsion is regarded as having  eclampsia until proven 
otherwise, the health care providers are supposed  to give a loading dose of magnesium 
sulphate as follows: 
 Insert IV line and give fluids slowly (normal saline or Ringer’s lactate) 1 litre in 6-8 
hours (3-ml/minute) . 
 Give 4-g of magnesium sulphate (20 ml of 20% solution) IV slowly over 20 minutes, 
and if woman conscious she must be warned that she would experience a warm 
sensation during the injection. 
AND: 
 Give 10 g of magnesium sulphate IM: give 5 g (10 ml of 50% solution) IM deep in 
upper outer quadrant of each buttock with 1 ml of 2% lignocaine in the same syringe. 
If unable to give IV, give IM only (loading dose) 
 Give 10 g of magnesium sulphate IM: give 5 g (10 ml of 50% solution) IM deep in 
upper outer quadrant of each buttock with 1 ml of 2% lignocaine in the same syringe. 
If convulsions recur 
 After 15 minutes, give an additional 2 g of magnesium sulphate (10 ml of 20% 
solution) IV over 20 minutes. If convulsions still continue, give diazepam and refer 
urgently. 
If referral delayed for long, or the woman is in late labour, continue treatment: 
 Give 5 g of 50% magnesium sulphate solution IM with 1 ml of 2% lignocaine every 4 
hours in alternate buttocks until 24 hours after birth or after last convulsion (whichever 
is later). 
 Insert a Foleys catheter to monitor urine output. 
 Before giving the next dose of magnesium sulphate, ensure: 
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 Knee jerk is present, urine output is greater than 100 ml in 4 hours and respiratory rate 
is above 16 breaths per minute. 
 DO NOT give the next dose if knee jerk is absent, urine output is less than 100 ml per 4 
hours and respiratory rate is less than16 breaths per minute.  
In case of respiratory depression (breathing less than 16 breaths per minute)  after magnesium 
sulphate,  do not  give any more magnesium sulphate, instead give the antidote: calcium 
gluconate 1 g IV (10 ml of 10% solution) over 10 minutes.  
 Give appropriate antihypertensive drug 
If diastolic blood pressure is more than 110-mmHg: 
 Give hydralazine 5 mg IV slowly (3-4 minutes). If IV not possible give IM. 
 If diastolic blood pressure remains more than 90 mmHg, repeat the dose at 30 minute 
intervals until diastolic blood pressure is around 90 mmHg. The dose must be limited to 
20 mg in total.  
 The patient must be referred as soon as possible 
 The woman must be accompanied by a health care provider during transport to ensure 
appropriate position; and in case of recurrent convulsion during the journey, to give 
magnesium sulphate and protect her from fall and injury. 
In case of in availability of magnesium sulphate or toxicity with magnesium sulphate, 
valium is recommended as follows: 
Loading dose IV 
� Give diazepam 10 mg IV slowly over 2 minutes 
� If convulsions recur, repeat 10 mg. 
Maintenance dose 
� Give diazepam 40 mg in 500 ml IV fluids (normal saline or Ringer’s lactate) titrated over 6-
8 hours to keep the woman sedated but rousable. 
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� Stop the maintenance dose if breathing is less than 16 breaths per minute. 
� Assist ventilation if necessary with mask and bag 
� Do not give more than 100 mg in 24 hours. 
� If IV access is not possible (e.g. during convulsion), give diazepam rectally. 
Documentation must be done of all findings and the care given to the patient; and immediately 
refer her. 
 
APPENDIX II:  I NTERVIEW GUIDE FOR PATIENTS’   INTERVIEWS  
1. Please tell me where you were referred from? 
2. What made you seek help from the health centre? 
 (Probe for onset of problem, recognition of problem. What did you think the problem was?) 
3. What happened at the health centre when you arrived? 
(Probe for: BP check, urine test, Intravenous infusion, catheterization, drugs given and 
information about drugs, communication with health care providers, who attended to her 
(midwife, medical assistant, clinical officer) 
6. How did you get to Chatinkha? 
7. How long did it take to get to this hospital if you can remember? 
  (Probe for: Problems with transportation) 
8. How did you feel being referred to this hospital? 
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APPENDIX III:  I NTERVIEW GUIDE FOR   INTERVIEWS WITH FIRST 
LEVEL HEALTH CARE PROVIDERS 
Introduction: Self introduction, name and general affiliation by researcher. 
Demographic information 
Ag……….. 
Marital status……… 
Religion…….. 
Profession…….. 
 
Purpose of Interview 
We are aware that pre-eclampsia is one of the conditions which are referred to Chatinkha 
Maternity Unit from most health centres.  We are interested in knowing your views about this 
problem and how it is managed.  It will be appreciated if we could spend some time together to 
discuss this issue. 
Interview Begins 
Clinical Experience 
1. How long have you been working as a (a clinical officer, medical assistant, midwife 
technician, enrolled midwife, registered midwife.)?   
2. How long have you been working at this clinic?   
3. What type of obstetric complications do you see at this health centre? 
3. How many obstetric complications do you see in a month on average?   
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4. Tell me about the last time you saw a patient with pre-eclampsia or eclampsia.  
Diagnosis 
1. How are patients with pre-eclampsia and eclampsia identified at this health centre? 
       2. Where exactly are patients of pre-eclampsia and eclampsia identified at this health centre? 
Management   
1. What do you do with patients with pre-eclampsia?   
2. What do you do with patients with eclampsia?   
3. What effect does the care you provide to these patients have on further management at QECH?  
5. What challenges do you meet when taking care of patients with severe pre-eclampsia and 
eclampsia? 
6. What suggestions do you have for improvement of care for patients with pre-eclampsia and 
eclampsia? 
7. What do you have at your health centre to effectively care for patients with pre-eclampsia and 
eclampsia?  
8. Is this adequate? If not, what is lacking in your health centre to effectively care for these 
patients? 
– If necessary, probe on equipment, and skills, supervision, drugs  other 
 
Availability and use of magnesium sulphate and hydralazine 
1. Is hydralazine and magnesium sulfate available here? (Ask if not mentioned on management 
section)  
2. How do you use magnesium sulphate? 
3. How do you choose patients to receive magnesium sulphate?  
4. How comfortable are you using this drug? 
5. Are there any other drugs you use to treat patients with pre-eclampsia and eclampsia apart 
from Magnesium sulphate? 
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APPENDIX IV:  INTERVIEW GUIDE FOR HEALTH CARE PROVIDERS AT 
QECH 
Introduction: Self introduction, name and general affiliation 
Purpose of Interview 
We are aware that preeclampsia is one of the conditions admitted to Chatinkha maternity 
unit from most health centres.  We are interested in knowing your views about the 
condition of patients on arrival to this unit.  It will be appreciated if we could spend some 
time together to discuss this issue. 
 
Interview Begins 
 
             Demographic information 
Age 
Marital status 
Religion 
 Profession 
 
Clinic Experience 
1. How long have you been working as a (a clinical officer, midwife technician, enrolled 
midwife, registered midwife)?   
2. How long have you been working at this hospital?   
3. How many obstetric cases do you see in a day on average?   
 
Experience with referred patients of severe preeclampsia and eclampsia 
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1. Would you please tell me what you understand by preeclampsia and eclampsia? 
2. The records indicate that yesterday you admitted a patient with severe preeclampsia /eclampsia 
from the health centre; would you please tell me about the patient? 
- Probe for condition of patient on arrival, escort from health centre, intravenous infusion, 
blood pressure check,  urinary catheter, documentation of what was done at the health  
centre) 
 
Instruction: If patient was sent from health centre without prior care ask the following 
questions 
 
3. What do you think made the patient arrive in the condition you just described? 
 
4. How did the condition of the patient affect your provision of care? 
 
5. In your opinion, how best would you want patients with severe pre-eclampsia or 
eclampsia to be managed before referral to this hospital? 
 
6. What challenges if any, do you think health care staff at the health centres face when 
trying to care for patients with pre-eclampsia and eclampsia? 
 
7. What should be done to improve management of patients with severe pre-eclampsia and 
eclampsia at the health centres? 
 
8.  How was the patient managed when she got here? 
 
 
Thank you for participating in this study. 
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APPENDIX V: FOCUS GROUP DISCUSSION GUIDE  
25
TH
 NOVEMBER, 2012 
TIME: STARTED 
TIME: FINISHED 
Participant characteristics 
Characteristic Total number 
Enrolled nurse midwife 1 
Nurse midwife technician 5 
Married 5 
Single 1 
Age range 25-56 
Work experience range 1 -26 
 
QUESTIONS 
PRE-ECLAMPSIA AND ECLAMPSIA AND USE OF MAGNESIUM SULFATE 
 How often do you see patients with pre -eclampsia and eclampsia in your health centres? 
 What do you do when you receive a patient with pre -eclampsia? 
 What do you do when you receive a patient with eclampsia? 
 How does the care you give benefit the patients and the people who receive them at the 
referral centre?  
 What has been your experience with the use of Magnesium sulphate? (Which patients 
get Magnesium sulphate?) 
 How do you feel using Magnesium Sulphate? (Factor that hinder or facilitate use of 
Magnesium sulphate) 
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 What other drugs do you use to manage patients with pre-eclampsia and eclampsia?  
Probe on hydralazine and policy on availability in health centres) 
 What challenges do you meet when managing patients with pre-eclampsia and eclampsia? 
TRANSPORT ISSUES 
How do you ensure safety of patients with eclampsia in your facilities and IN TRANSIT to 
Queens? 
SUPERVISION AND FEEDBACK 
 What supervision do you receive from the DHO for complications such as pre-eclampsia 
and eclampsia? 
 What supervision would you like to have? (Frequency, type) 
 What feedback do you receive for patients you send to Queens?  
 What feedback would you like to receive when you send patients to Queens? 
SUPPLIES 
How often do you order supplies from DHO? 
Probe: BP machines 
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APPENDIX VI: INTERVIEW GUIDE FOR PATIENTS CHICHEWA VERSION 
1. Kodi munatumizidwa kuchokela chipatala chakuti? 
2. Kodi ndizizindikilo zanji zomwe zinakupangitsani kuti muganize zopita kuchipatala? 
3. Kodi zizindikilo zimenezi munayamba kuziona liti? 
4. Kodi mutaona zizindikilo zimenezi mumaganiza kuti lingathe kukhala bvuto lanji? 
5. Mutafika kuchipatala chaching’ono anakulandilani ndikukusamalani bwanji? 
(Probe for: BP check, urine test, Intravenous infusion, catheterization, drugs given and 
information about drugs, communication with health care providers, who attended to here 
(midwife, medical assistant, clinical officer) 
6. Kodi munayenda bwanji /munabwela bwanji kuchipatala kuno? 
7. Kodi zinatenga nthawi yayitali bwanji kuti mufike kuchipatala kuno ngati 
mungakumbukile bwinobwino? 
8. Kodi munamva bwanji muntima mwanu atakuuzani kuti mutumizidwa kuchipatala 
chachikulu chino? Probe Chifukwa chiani mumamva choncho? 
9. Anakupelekazani ndi ndani pa ulendo wobwera ku Chatinkha kuno? 
10. Kodi ndi adokotala ati omwe anakupelekezani pa ulendo wanu wobwera kuno?  
( probe for midwife , clinical officer , HAS) 
 
Zikomo kwambiri polowa nawo mkafukufuku 
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APPENDIX VII: INTERVIEW GUIDE CHICHEWA VERSION - FIRST LEVEL 
HEALTH CARE PROVIDERS 
Introduction: Self introduction, name and general affiliation 
Demographic information 
Age ---------------------------------------------------------------------------------- 
Marital status---------------------------------------------------------------------- 
Religion------------------------------------------------------------------------------ 
Profession------------------------------------------------------------- 
 
Purpose of Interview 
We are aware that preeclampsia is one of the conditions that are referred to Chatinkha Maternity 
Unit from most health centres. We are interested in knowing your views about this problem and 
how it is managed. It will be appreciated if we could spend some time together to discuss this 
issue. 
Interview Begins 
Clinical Experience 
1. Mwakhala mukugwira ntchito kwanthawi yaitali bwanji paudindowa (clinical officer, 
midwife)?  
2. Mwagwira ntchito kwanthawi yaitali bwanji pachipatala chino?   
3. Kodi ndi mavuto anji omwe mumalandira pa chipatala pano okhuzana ndi uchembere? 
4. Kodi ndi amayi angati omwe amagonekedwa ndi bvuto lonkhuzana ndiuchembere 
patsiku? 
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5. Kodi pa mwezi mumalandira amayi angati omwe moyo wawo uli pachiopsyezo chifukwa 
cha zovuta zina zobwera chifukwa cha uchembere? 
6. Ndiliti lomwe munasamalirako mzimayi woyembekezera wokhala ndi bvuto lothamanga 
magazi? 
 
 
 
Diagnosis 
1. Amayi woyembekezera womwe ali ndi bvuto lothamanga magazi mumawazindikira 
bwanji? 
2. Amayi amene ali ndi bvuto lothamanga magazili mumawapeza kuti? 
 
Management   
1. Nanga amayi woyembekezera womwe a kukomoka chifukwa chothamanga magazi 
mumatani nawo akafika pachipatala pano? 
2. Kodi umu ndi mmene mumawasamalira amayi wothamanga magaziwa nthawi zonse 
kapena pali zina zomwe mumachita powasamalira? Ngati zilipofotokozani? 
3. Kodi chisamaliro chomwe mumawapatsa amayi othamanga magazi kapena okomoka 
chifukwa chothamanga magazi musanawatumize kuchipatala chachikulu nchofunika 
bwanji kapena chimawanthandiza bwanji akapita kuchipatala chachikulucho? 
Ndi zovuta zanji zomwe mumakumana nazo posamalira amayi omwe ali ndi bvuto 
lothamanga magazi kapena omwe akukomoka chifukwa chothamanga magazi? 
4. Kodi inu mukuganiza kuti njira yabwino yosamalira amayi omwe akuthamanga magazi 
kapena kukomoka chifukwa chakuthamanga magazi ingakhale yiti? 
5. Kodi ndi zinthu ziti zomwe muumagwiritsa ntchito posamalira amay amenewa? 
6. Kodi zinthuzo ndi zokwanira posamalira amayi omwe ali ndi bvutoli? 
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Probe: Muli ndizosowa zanji zomwe zimakusokonezani kusamalira bwino amayi omwe 
akuthamanga kapena kukomoka chifukwa chothamanga magazi? (Probe on equipment, and 
skills, supervision, drugs, other) 
Availability and use of magnesium sulphate and hydralazine 
1. Kodi muli ndi hydralazine ndi Magnesium sulfate? 
(Ngati ayi, kodi nthawi zina mumakhala naye?,ndiliti lomwe munalandira/ order mankhwalawa)  
2. Mumasankha bwanji wodwala woyenera kulandira mankhwalawa?  
3. Kodi mankhwalawa mumawagwiritsa ntchito bwanji?  
4. Kodi pali mavuto ena ali onse omwe mumakumananawo chifukwa chogwiritsa ntchito 
mankhwalawa? 
5. Kodi ndi chiyembekezo changi kapena  nkhawa zanji zomwe mumakhala nazo pogwiritsa 
ntchito mankhwalawa? 
6. Kodi chiyembekezo kapena nkhawa zimenezi zimakhuza bwanji dongosolo longwiritsa 
ntchito kapena loperekela mankhwalawa? 
7. Kodi pali mankhwala enanso omwe mumagwiritsa ntchito posamalira amayi omwe 
akuthamanga magazi kapena kukomoka chifukwa chothamanga magaziwa? 
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APPENDIX VIII: INTERVIEW GUIDE CHICHEWA VERSION - HEALTH 
CARE PROVIDERS AT QECH 
 
Introduction: Self introduction, name and general affiliation 
 
Purpose of Interview 
We are aware that preeclampsia is one of the conditions admitted to Chatinkha Maternity 
Unit from most health centres.  We are interested in knowing your views about the 
condition of patients on arrival to this unit.  It will be appreciated if we could spend some 
time together to discuss this issue. 
 
Interview Begins 
Demographic information 
Age------------------------------------years 
Marital status------------------------------------------------------------------------------------------ 
Religion-------------------------------------------------------------------------------------------------- 
Profession----------------------------------- 
Clinic Experience 
1. Mwakhala mukugwira ntchito kwanthawi yaitali bwanji ngati( doctor, midwife, etc) ? 
2. Mwagwira ntchito kwanthawi yaitali bwanji pachipatala chino?   
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3. Ndi amayi angati omwe amagonekedwa pachipatala pano chifukwa cha mabvuto 
wokhudzauchembere pa tsiku?  
4. Kodi ndi amayi angati omwe amagonekedwa pamwezi chifukwa choti moyo wawo uli 
Pachiopsyezo chifukwa chauchembere? 
Experience with referred patients of severe preeclampsia and eclampsia 
1. Kodi mumamvetsa bwanji zamatenda wothamanga magazi kapena kukomoka chifukwa 
cha kuthamanga kwa magazi kwa a amayi woyembekezera (pre-eclampsia and 
eclampsia)? 
2. Kawundula akuonetsa kuti dzulo munagoneka mayi wodwala matenda wothamanga 
magazi kapena kukomoka chifukwa cha kuthamanga magazi wochokela ku health centre. 
Mungandifotolezereko zammene analiri wodwala ameneyu nthawi imene amafika kuno?  
Probe for condition of patient on arrival, escort from health centre, intravenous 
infusion, blood pressure check,  urinary catheter, documentation of what was done at 
the health centre 
 
3. (Ngati wodwala sanali bwino, funsani) Kodi mukuganiza kuti mayi ameneyu anafika ali 
wodwalika choncho chifukwa chiyani? 
 
4. Kodi m’mene anafikila wodwalayu makamaka mmene amawonekera (condition) 
mukuganiza kuti zinakuthandizani bwanji kapena zinabwenzeletsa mbuyo bwanji 
kasamalidwe kawodwala ameneyu ? 
 
5. Kodi mmaganizo anu mukuona kuti amayi amenewa azisamalidwa bwanji 
asanatumizidwe kuchipatala chachikulu chino? 
 
6. Kodi mukuganiza kuti ndi zobvuta zanji zomwe anamwino kapena ma clinical officer 
akuzipatala zing’onozing’ono (health centre) amakumana nazo posamalira amayi omwe 
ali ndibvuto lothamanga magazi kapena womwe akukomoka chifukwa chothamanga 
magazi asanawatumize kuno ku Chatinkha? 
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7. Kodi mukuganiza kuti anthu ogwira ntchito ku zipatala zazingo’nozing’onowa 
angathandizidwe bwanji kuti azitha kusamalira bwino amayi woyembekezera omwe 
apezeka ndi bvuto lothamanga magazi asanatumizidwe ku Chatinkha kuno? 
 
 
Zikomo kwambiri polowa nawo mkafukufuku 
 
 
 
 
APPENDIX IX:  MAIN AND SUB- THEMES  
Main category Sub themes 
Knowledge about condition Ability to describe conditions 
Ability to recognise condition 
Ability to detect condition 
Management of preeclampsia Counselling and regular follow up 
Antihypertensive and referral 
Referral to hospital 
Management of eclampsia Resuscitation with iv fluids and referral 
Resuscitation with iv fluids, magnesium 
sulphate and refer 
Perceived benefit of pre-referral care Prevention  of further complications like injury, 
convulsions, deaths 
Facilitates care at referral facility 
Reduces work for staff at referral facility 
Fulfilment of personal responsibility as health 
centre staff 
 
Challenges to proper management  
Patient related Knowledge about condition 
Delay in reporting to health centre 
Noncompliance to referral 
 
Health professional related Lack of refresher courses 
Rarity of condition leading to forgetfulness 
Lack of experience with management of 
condition 
Fears and poor perceptions about magnesium 
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sulphate 
 
 Related to health centre capacity Lack of resources- essential resources e.g.Bp 
machines, drugs, albumin sticks 
Shortage of staff  
Transportation problems 
 
  
 
Related to health centre administration Lack of regular and supportive management 
Lack of feedback from referral facility 
 
 
 
 
APPENDIX X: REK APPROVAL 
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APPENDIX XI: COMREC CERTIFICATE OF APPROVAL 
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APPENDIX XII: LETTER OF PERMISSION FROM BLANTYRE DISTRICT 
HEALTH OFFICE 
 
 
 
   
 
126 
 
 
APPENDIX XIII: LETTER OF PERMISSION FROM QUEEN ELIZABETH 
CENTRAL HOSPITAL 
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APPENDIX XIV: CONSENT FORM FOR HEALTH CARE PROVIDERS 
 
Title: Perspectives of first level health care providers on the management of pre-eclampsia 
and eclampsia in Blantyre, Malawi 
Statement of the study 
Purpose 
I invite you to participate in this study of “Management of preeclampsia and eclampsia: 
perspectives from first level health care providers” 
The objective of this study is to describe first level health care providers’ perspectives on the 
management of patients with preeclampsia and eclampsia before referral to the hospital and to 
identify gaps in, and challenges to the management of patients with preeclampsia and eclampsia 
at the first level of care 
Procedures 
 
Specifically, I will ask you for information about your work in relation to preeclampsia and 
eclampsia, things that make the management of patients with preeclampsia and eclampsia easier 
for you, barriers to proper management of preeclampsia and eclampsia, what you would want 
improved to facilitate better management of preeclampsia and eclampsia. I will also ask you 
some background information which will not include your name. 
Should you agree to take part in the study, there is a chance that I will contact you again to re-
interview   in order to clarify any information which you might have given me in the initial 
interview.  
The interview will take approximately 45 to 50 minutes of your time and you may find some of 
the questions asked psychologically disturbing.  
The information that you provide during the study will be kept confidential. Only the interviewer 
and researchers will have access to the audio taped interviews and the transcripts thereof. This 
information will be destroyed on completion of the study. 
 
Benefits of the study 
By participating in this study and answering our questions, you will help to increase our 
understanding on how patients of preeclampsia and eclampsia are managed at this level of care. It 
would also help you as a health care provider to reflect upon your own efforts in the management 
of preeclampsia and eclampsia. We hope that the results of the study will improve the quality of 
care rendered to patients with preeclampsia and eclampsia. 
 
Your participation in this study is voluntary and you have the right to refuse to participate 
or answer any questions with which you feel uncomfortable. If you change your mind about 
participating during the course of the study, you have the right to withdraw at any time. The 
decision to withdraw will not affect your work or position in anyway. 
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If there is anything that is unclear or you need further information, I shall be delighted to 
provide it. 
 Do you have any questions that you would like me to clarify? 
 
Declaration of volunteer: 
I have understood that the purpose of the study is to describe first level health care providers’ 
perspectives on the management of patients with preeclampsia and eclampsia before referral to 
the hospital and to identify gaps in, and barriers to the management of patients with preeclampsia 
and eclampsia at the first level of care 
I realize that I might be contacted again in a few weeks to be re-interviewed  for further 
clarification of the information I give in the initial interview. 
I have read the above information, or it has been read to me. I have had the opportunity to ask 
questions about it and any questions that I have asked have been answered to my satisfaction. I 
consent voluntarily to participate as a subject in this study and understand that I have the right 
to withdraw from the study at any time without in any way affecting my work position. 
 
Signature of volunteer:                                                   Signature of investigator: 
 
 
 
Date:___________________________________         Date:_________________________ 
If you have any further questions or concerns about the study contact me or my supervisor on the 
following addresses   
Ass.Professor A.Malata .Kamuzu College of Nursing. 
Phone  Number:0999963373 
 Or Josephine Changole .College of Medicine, Department of Obstetrics and Gynaecology 
Phone Number: 0888311537 
If you have any safety concerns about the study, please  do not hesitate  to contact: the 
COMREC secretariat at College of medicine, P/Bag 360, Chichiri. Phone: +265 1 874 377 
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APPENDIX XV: CONSENT FORM FOR PATIENTS 
 
Title: Perspectives of first level health care providers on the management of pre-eclampsia 
and eclampsia in Blantyre, Malawi 
 
Statement of the study 
Purpose 
I invite you to participate in this study of “Perspectives of first level health care providers on the 
management of pre-eclampsia and eclampsia in Blantyre, Malawi” 
The objective of this study is to describe first level health care providers’ perspectives on the 
management of patients with preeclampsia and eclampsia before referral to the hospital and to 
identify gaps in, and challenges to the management of patients with preeclampsia and eclampsia 
at the first level of care. 
Procedures 
 
Specifically, I would like your permission to review your records to determine if you are eligible 
for the study or not. Should you be eligible for the study, I will ask you for information about 
your experience with care at the health centre before you were referred to this hospital. The 
interview will take approximately 45 to 50 minutes of your time. 
The information I will obtain from your records and that you provide during the study will be 
kept confidential. Only the interviewer and researchers directly involved in this study will have 
access to the audio taped interviews and the transcripts thereof. This information will be secured 
in a password protected computer on completion of the study. 
 
Benefits of the study 
By participating in this study and answering our questions, you will help to increase our 
understanding on how patients of preeclampsia and eclampsia are managed at the health centre. 
We hope that the results of the study will improve the quality of care rendered to patients with 
preeclampsia and eclampsia. 
 
Your participation in this study is voluntary and you have the right to refuse to participate 
or answer any questions  which you feel uncomfortable with. If you change your mind about 
participating during the course of the study, you have the right to withdraw at any time. The 
decision to withdraw will not affect your  care in anyway. 
If there is anything that is unclear or you need further information, I shall be delighted to 
provide it. 
 Do you have any questions that you would like me to clarify? 
 
Declaration of volunteer: 
I have understood that the purpose of the study is to describe first level health care providers’ 
perspectives on the management of patients with preeclampsia and eclampsia before referral to 
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the hospital and to identify gaps in, and barriers to the management of patients with preeclampsia 
and eclampsia at the health centre 
I have read the above information, or it has been read to me. I have had the opportunity to ask 
questions about it and any questions that I have asked have been answered to my satisfaction. I 
consent voluntarily to participate as a subject in this study and understand that I have the right 
to withdraw from the study at any time without in any way affecting  the care rendered to me. 
 
 
Signature of volunteer:                                                       Signature of investigator: 
 
 
 
 
Date: _____________________________                        Date:__________________________ 
 
If you have any further questions or concerns about the study, you can  contact me or my 
supervisor on the following addresses   
Associate ProfessorA. Malata .Kamuzu College of Nursing. 
Phone Number:0999963373 
 Or Josephine Changole .College of Medicine, Department of Obstetrics and Gynaecology 
Phone Number: 0888311537 
If you have any safety concerns about the study, please  do not hesitate  to contact: the 
COMREC secretariat at College of medicine, P/Bag 360, Chichiri. Phone: +265 1 874 377 
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APPENDIX XVI: CONSENT FORM FOR HEALTH WORKERS CHICHEWA 
VERSION 
 
Title: Perspectives of first level health care providers on the management of pre-eclampsia 
and eclampsia in Blantyre, Malawi 
Kalata yopempha chilolezo  
 
Cholingacha kafukufuku 
 
Tikukupemphani kuti mulowe nawo mu kafukufuku wofuna kumva maganizo awogwira ntchito 
pa health centre pa zakasamalidwe ka amayi omwe apezeka ndi bvuto lothamanga magazi kapena 
kukomoka chifukwa cha kuthamanga magazi asanatumizidwe ku chipatala chachikulu. Cholinga 
ndi chofuna kudziwa zinthu zomwe zimakulimbikitsani ndi zinthu zomwe zimakufowoketsani pa 
kasamalidwe ka amayi woyembekezera amene a pezedwa ndi bvuto lothamanga magazili 
asanatumizidwe kuchipatala chachikulu. 
 
Ndondomeko ya kafukufuku 
 
Makamaka tikufuna kudziwa zomwe mumachita posamalira amayi woyembekezera omwe 
apezeka ndi bvuto lothamanga magazi kapena kukomoka kumene chifukwa cha 
bvutoli.Tifunanso kudziwa zinthu zomwe zimakuthandizani kuti muwasamalile bwino amayiwa 
komanso zinthu zomwe zimakufowoketsani.Tifunanso kudziwa zinthu zomwe mungakonde kuti 
zichitike kuti ntchito yosamalila amayi omwe apezeka ndi bvutoli yikhale yopambana. 
Tikufunsaninso zinthu zina zokhudzana ndi inu,komasitisowa kudziwa dzina lanu. 
Ngati mubvomera kutenga nawo mbali mu kafukufuku ameneyu ,mwina pangadzafunike kuti 
ndidzacheze nanunso pa zinthu zomwe mwina sizinamveke bwino pa kukambilana kwathu 
koyamba. 
 
Zokambilana zathu zidzatenga pafupifupi mphindi makumi anayi ndi zisanu kapena makumi 
asanu (45 to 50 minutes) yanthawi yanu.Pofuna kuti tisaphonye china chilichonse pazokambirana 
zathu, ndikukupemphani kuti mundilore kujambula zokambiranazi pa tape recorder iyi.Mawu anu 
sadzaulutsidwa pawireless kapena pa kanema wina aliyense. 
 
Mwina ndi mwina mutha kupeza kuti mafunso ena atha kukhala okukhudzani/okusautsani 
m’maganizo.Ndifunakupepeselatu ngati izi zingachitike chifukwa sicholinga change kutelo. 
Ndikoyenera kukudziwitsaninso kuti zonse zomwe titakambilane pano zidzakhala za chinsisi 
chenicheni.Wokhawokha okhudzidwa ndi kafukufukuyu ndi omwe angapeze mwayi wogwilitsa 
nchito zotsatila zakafukufukuyu.Zokambilanazi zidzalembedwa ndi kusungidwa bwino lomwe 
mu komputa yomwe ili ndi chitetezo chokwanira kusukulu yaukachenjede ya Oslo mdziko la 
Norway, komwe ndikuchita ma phunziro omwe ndikuchitira kafukufuku ameneyu. 
 
Phindu la kafukufuku ameneyu 
Potenga nawo mbali mu kafukufukuyu ndi kuyankha mafunso athu mudzatithandiza kumvetsa 
bwino momwe amayi abvuto lothamanga magazi kapena lokomoka chifukwa chothamanga 
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magazi amasamaliridwa pa chipatala chino asanatumizidwe ku chipatala chachikulu. 
Zidzathandiza inunso ngati wosamalila odwala kulingalira ntchito yabwino imene mumagwira 
polingalira ndi kudzipeleka kwanu posamalira odwala amenewa.Tili ndi chikhulupiliro kuti 
zotsatila zakafukufukuyu zitithandiza kupititsa pa tsogolo kasamalidwe ka amayi omwe ali 
ndibvuto lothamanga magazi kapena  kukomoka chifukwa chothamanga magazi. 
 
Simukukakamizidwa kuyankha funso liri lonse lomwe simuli wokonzeka kuyankha kapena funso 
lomwe lingakusowetseni mtendere mu mtima. Dziwani kuti ndinu womasuka kusiya 
kafukufukuyu nthawi ina iliyonse ngati kungafunike kutero.Dziwaninso kuti kutuluka 
mkafukufuku sikudzasokoneza kagwiridwe kantchito yanu kapena udindo wanu pa ntchito. 
 
Kodi muli ndi funso lina lililonse pa zomwe ndakufotokozelanizi kapena zomwe mwawelengazi? 
 
Kuvomeleza kulowa mu kafukufuku 
Ndamvetsa kuti cholinga cha kafukufukuyu ndi kufuna kumva maganizo awogwira ntchito ku 
health centre pa zakasamalidwe ka amayi omwe apezeka ndi bvuto lothamanga magazi kapena 
kukomoka chifukwa cha kuthamanga magazi asanatumizidwe kuchipatala chachikulu. 
 
Ndikuzindikila kuti ndikhonza kudzayenderedwanso ndi kufunsidwa mafunso ena popitiliza 
kufotokozera motsindika zokambilana zokhudza kafukufukuyu potsatila zokambilana zathu 
zoyamba. 
 
Ndawerenga dogosolo lonse lakafukufuku ameneyu ndipo ndakhalanso ndi mwayi ofunsa 
mafunso pa dongosololi ndipo ndalandira mayankho omwe ndakhutila nawo.Choncho 
ndikubvomera mwaufulu ndi mwakufuna kwanga kutenga nawo mbali mkafukufukuyu.Komanso 
ndikuzindikira kuti ndili ndiufulu wotuluka mkafukufukuyu nthawi yina iliyonse ngati nditafuna 
kutelo, ndipo izi sizidzasokoneza ntchito kapena udindo wanga pantchito. 
 
Signature of volunteer:                                                   Signature of investigator: 
 
 
 
Date:                                                                                  Date: 
Ngati mungakhale ndi mafunso ena okhuza kafukufuyu , musakaike kundifunsa ine kapena 
aphunzitsi anga pa malamya ali mmusiwa: 
Ass.Professor A. Malata .Kamuzu College of Nursing. 
Phone Number:0999963373 
Or Josephine Changole . College of Medicine, Department of Obstetrics and Gynaecology 
Phone Number: 0888311537 
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APPENDIX XVII: CONSENT FORM FOR MOTHERS CHICHEWA VERSION 
 
Title: Management of preeclampsia and eclampsia: perspectives from first level health care 
providers 
 
Cholinga cha kafukufuku 
Tikukupemphani kuti mulowe nawo mu kafukufuku wofuna kumva maganizo awogwira ntchito 
pa health centre pa zakasamalidwe ka amayi omwe apezeka ndi bvuto lothamanga magazi kapena 
kukomoka chifukwa cha kuthamanga magazi asanatumizidwe kuchipatala chachikulu. Cholinga 
ndichofuna kudziwa zinthu zomwe zimawalimbikitsa ndi zinthu zomwezi mawafowoketsa pa 
kasamalidwe ka  amayi amene apedzedwa ndi bvuto limeneli asana tumizidwe kuchipatala 
chakikulu. 
 
Ndondomeko ya kafukufuku 
 
Makamaka tikufuna kupempha kuti mutilore kuona nawo mbiri yamatenda anu mmabuku anu 
akuchipatala kuno kuti tidziwe ngati kuli koyenera kuti mulowe nawo mkafukufuku.Ngati 
zolembedwazo zikusonyeza kuti muthakulowa nawo mkafukufuku, tidzakupemphani kuti 
mutithandize poyankha  mafunso. Mafunso ake ndi wofuna kudziwa momwe munalandilidwira 
ndi momwe munasamalidwira mutafika / pezeka ndi bvuto lothamanga magazili kuchipatala 
chachingo’no(health centre). Ndikufunsaninso zinthu zina zokhudzana  ndi inu koma 
sindidzafuna kudziwa dzina lanu. 
 
Zokambilana zathu zidzatenga pafupifupi phindi  makumi anai ndi asanu kapena makumi asanu  
(45 t0 50 minutes)  yanthawi yanu.Ndikukupemphani kuti  mundilole kuti zokambirana zathu 
zijambulidwe pa tape recorder iyi kuti tisamphonye  china chili chonse chomwe tidzakambirane. 
Ndikukutsimikizirani kuti zokambiranazi  ndi zachinsinsi , ndipo sizidzaulutsidwa pa wireless 
kapena pa kanema wina aliyense. Ndipo zonse zomwetitakambilane pano zidzakhala 
zachinsisi.Wokhawokha okhudzidwa ndi kafukufukuyu ndi omwe angapeze mwayi wogwiritsa 
ntchito zokambirana kepena zotsatila za kafukufukuyu. 
 
Zokambiranazi zidzalembedwa bwino lomwe mumakina a kompyuta yomwe ili ndi chitetezo 
chokwanira kusukulu yaukachenjede ya Oslo ku Norway komwe ndikuchita maphunziro omwe 
ndikupangira kafukufukuyu. 
 
Mphindu la kafukufuku 
Potenga nawo mbali mu kafukufukuyu ndi kuyankha mafunso athu mudzatithandiza kumvetsa 
bwino momwe amayi othamanga magazi kapena okomoka chifukwa chothamanga magazi 
amasamalidwira pa chipatala chaching’ono asanatumizidwe  ku chipatala chachikulu chino. 
 
Tili ndi chikhulupiliro kuti zotsatila zakafukufukuyu zidzatithandiza kupititsa pa tsogolo 
kasamalidwe kabwino kaamayi omwe ali ndi vuto lothamanga magazi kapena akukomoka 
chifukwa chothamanga magazi. 
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Simuliwokakamizidwa kuyankhafunso lomwe simuliokonzeka kutero . Ndipo zindikilani kuti 
ndinu omasuka kutuluka mkafukufukuyu nthawi ina iliyonse mutafuna kutero. Kutuluka 
mkafukufuku sikudzasokoneza chisamaliro chanu pachipatala pano. 
 
Kodi muli ndi funso lina lililonse pa zomwe nda kufotokozeranizi kapena zomwe mwawelengazi 
zokhuzana ndi kafukufukuyu? 
 
Kuvomelezakulowa mu kafukufuku 
Ndamvetsa kuti cholinga cha kafukufukuyu ndi kufuna kumva maganizo awogwira ntchito ku 
health centre pa zakasamalidwe ka amayi woyembekezera omwe apezeka ndi bvuto lothamanga 
magazi kapena kukomoka chifukwa cha kuthamanga magazi asanatumizidwe kuchipatala 
chachikulu, pofuna kupititsa patsogolo kasamalidwe kabwino ka amayi womwe apezeka ndivuto 
limeneli. 
 
Ndawerenga ndi pondakhala ndi mwayi ofunsa mafunso ,ndipo ndalandira mayankho omwe 
ndakhutiranawo. 
Ndikuvomereza mwakufuna kwanga kutenga mbali mkafukufukuyu.Ndipo ndikuzindikira kuti 
ndili ndiufulu wotuluka mkafukufukuyu nthawi ina iliyonse ngati nditafuna kutelo. Ndipo 
ndauzidwa kuti kutuluka mkafukufuku sikudzasokoneza mpango’no pomwe chisamaliro chomwe 
ndikulandira pachipatalapano. 
 
 
 
Signature of volunteer:                                                   Signature of investigator: 
 
 
 
Date:                                                                                  Date: 
 
Ngati mungakhale ndi mafunso ena okhuza kafukufuyu , musakaike kundifunsa ine kapena 
aphunzitsi anga pa malamya ali mmusiwa: 
Ass.Professor A. Malata .Kamuzu College of Nursing. 
Phone Number:0999963373 
Or Josephine Changole . College of Medicine, Department of Obstetrics and Gynaecology 
Phone Number: 0888311537 
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